# Chapter 21: Catatonic Disorder Due to Another Medical Condition

# The Biological and Neurological Basis of Catatonic Disorder Due to Another Medical Condition

## Introduction

Catatonic Disorder Due to Another Medical Condition represents a complex and often severe neuropsychiatric syndrome characterized by a constellation of psychomotor disturbances (Dodd, 2007; Mohr, 2022). The clinical presentation is markedly heterogeneous, encompassing a spectrum from profound motor inhibition (stupor, mutism, negativism) to excessive and purposeless motor activity (excitement, agitation) (Devine, 1914; Rosebush & Mazurek, 2007). Other cardinal features include bizarre posturing, catalepsy (waxy flexibility), stereotypies, mannerisms, grimacing, and echophenomena such as echolalia and echopraxia (Ilbeigi et al., 1998; Shams et al., 2010; Dodd, 2007). Historically, catatonia was conceptualized primarily as a subtype of schizophrenia (Dodd, 2007; Rosebush & Mazurek, 2007). However, contemporary understanding, reflected in modern diagnostic systems, recognizes catatonia as a transnosological syndrome that can occur in the context of various primary psychiatric illnesses—most notably mood disorders—as well as a direct pathophysiological consequence of numerous nonpsychiatric medical conditions (Mohr, 2022; Elyasi, 2016; Connell et al., 2022).

Catatonic Disorder Due to Another Medical Condition is diagnosed when there is evidence from the history, physical examination, or laboratory findings that the disturbance is the direct physiological consequence of an underlying medical illness (Ilbeigi et al., 1998; Fink, 2010). The range of implicated medical conditions is vast and includes neurologic disorders (e.g., encephalitis, stroke, traumatic brain injury, tumors), systemic metabolic disturbances (e.g., diabetic ketoacidosis, hypercalcemia, hepatic encephalopathy), autoimmune conditions, infections, and toxic states arising from medications or substances (Mohr, 2022; Ilbeigi et al., 1998; Connell et al., 2022). The profound disruption of motor control, behavior, and volition seen in this disorder points to a significant, albeit incompletely understood, disturbance of central nervous system function. The clinical overlap with symptoms of primary psychiatric and neurological diseases often creates diagnostic challenges, leading to under-recognition and delayed treatment, which can increase morbidity and mortality (Elyasi, 2016; Connell et al., 2022).

This chapter aims to provide a comprehensive overview of the biological and neurological mechanisms that are believed to underlie Catatonic Disorder Due to Another Medical Condition. By synthesizing evidence from neuropharmacology, neuroanatomy, genetics, and neuroimaging, we will explore how diverse medical pathologies can converge upon a common final pathway of psychomotor dysregulation. We will examine the roles of specific neurotransmitter systems, neural circuits, and brain regions implicated in the expression of catatonic signs. Furthermore, we will discuss the contribution of genetic factors, developmental vulnerabilities, and neuroplastic changes to the pathophysiology of the disorder. A deeper understanding of these biological underpinnings is not merely an academic exercise; it is fundamental to refining diagnostic approaches, developing targeted therapeutic interventions, and ultimately improving outcomes for patients afflicted with this debilitating condition.

## Neurobiological Systems

The clinical manifestations of catatonia, spanning motor, affective, and behavioral domains, are thought to arise from the dysregulation of several interconnected neurobiological systems (Dodd, 2007; Mohr, 2022). While no single mechanism can account for all cases, research points to a convergence of various medical insults upon a core set of neurotransmitter pathways and neural circuits that are critical for motor initiation, emotional regulation, and goal-directed behavior (Pontius, 1984; Nambu, 2012). The primary systems implicated include GABAergic, dopaminergic, and glutamatergic pathways, with modulatory influences from serotonin and norepinephrine (Dodd, 2007; Batinić et al., 2017).

### Neurotransmitter Systems and Neuropharmacology

**Gamma-Aminobutyric Acid (GABA) System:**
A substantial body of evidence points to a primary role for dysfunction in the GABA system, the brain's main inhibitory network (Dodd, 2007; Söderpalm, 2002). A state of profound cortical GABA deficiency is considered a leading hypothesis for the pathophysiology of catatonia (Naguy, 2015). This hypothesis is strongly supported by the dramatic and often rapid efficacy of benzodiazepines, which are positive allosteric modulators of the GABA-A receptor, as a first-line treatment for catatonia (Ogunlela & Raai, 2022; Mohr, 2022; Fernandez-Robles et al., 2015). The administration of agents like lorazepam can resolve catatonic signs, sometimes within minutes, suggesting a direct reversal of an underlying inhibitory deficit (Ogunlela & Raai, 2022). Medical conditions that lead to catatonia may do so by disrupting GABAergic function. For example, autoimmune encephalitis can produce antibodies that target GABA receptors, and metabolic encephalopathies can disrupt the cellular environment necessary for normal inhibitory neurotransmission (Connell et al., 2022; Muniz et al., 2024). Furthermore, some research in schizophrenia, a condition often associated with catatonia, has suggested a loss of GABAergic neurons in key brain regions like the hippocampus, which could lead to a state of disinhibition and subsequent downstream effects on dopamine systems (Dodd, 2007). The unexpected arousal effect of the GABAergic anesthetic etomidate in a patient with steroid-induced catatonia further highlights the complex and potentially paradoxical role of this system (Ilbeigi et al., 1998).

**Dopamine System:**
The dopamine hypothesis, originally developed for schizophrenia, also has significant relevance to catatonia (Dodd, 2007; Wise, 1982). This system is crucial for the initiation and regulation of voluntary movement, motivation, and reward (Kalivas, 2003). Both hyper- and hypo-dopaminergic states have been implicated in catatonia, potentially explaining the dichotomy between excited and retarded forms of the disorder (Rosebush & Mazurek, 2007). Hyperactivity of the dopamine system, particularly at the D2 receptor, is thought to be important for positive psychotic symptoms and may contribute to the psychomotor agitation seen in excited catatonia (Dodd, 2007; Fontalba-Navas & Caparros-del-Moral, 2015). Conversely, a state of dopamine blockade or hypoactivity, especially in frontal-striatal circuits, could underlie the akinesia, mutism, and stupor of retarded catatonia (Frith, 1987). This is clinically supported by the observation that antipsychotic medications, which are D2 receptor blockers, can sometimes induce or worsen catatonic symptoms, leading to conditions like neuroleptic malignant syndrome (NMS), which shares significant clinical overlap with malignant catatonia (Ogunlela & Raai, 2022; Connell et al., 2022). Medical conditions such as encephalitis or stroke affecting the basal ganglia can directly damage dopaminergic pathways, precipitating catatonic states (Dodd, 2007; Nambu et al., 2014).

**Glutamate System:**
Glutamate is the brain's primary excitatory neurotransmitter, and its dysregulation is increasingly recognized as a key factor in major psychiatric and neurological disorders (Söderpalm, 2002). A state of glutamate excitotoxicity, which can occur in conditions such as anoxia, ischemia, or stroke, leads to neuronal damage and can disrupt the delicate balance of neural circuits, potentially precipitating catatonia (Pujol & Puel, 1999; Sokolowski et al., 2024). The N-methyl-D-aspartate (NMDA) receptor, a subtype of glutamate receptor, is of particular interest. Anti-NMDA receptor encephalitis is a well-described autoimmune condition that frequently presents with prominent catatonic features, directly linking glutamatergic dysfunction to the syndrome (Connell et al., 2022; Bykov et al., 2024). This provides a strong rationale for the use of NMDA antagonists in treatment. Indeed, there are reports of catatonic symptoms in frontotemporal dementia responding to acamprosate, a drug with putative NMDA-antagonistic activity (Naguy, 2015). This suggests that in some medical conditions, a state of glutamate-mediated hyperexcitability may be a core pathophysiological driver of catatonia (Muniz et al., 2024).

**Other Neurotransmitter Systems:**
Serotonin and norepinephrine, while less directly implicated in the core motor symptoms of catatonia, play crucial modulatory roles in mood, anxiety, and arousal, all of which are frequently disturbed in catatonic patients (Dodd, 2007; Batinić et al., 2017). The autonomic instability seen in malignant catatonia, such as tachycardia, hypertension, and hyperthermia, points to a profound dysregulation of central autonomic control, in which these monoaminergic systems are heavily involved (Connell et al., 2022; Rosebush & Mazurek, 2007). It is also critical to consider these systems in the differential diagnosis, as conditions like serotonin syndrome, which involves serotonergic hyperstimulation from medications, can mimic catatonia (Rastogi et al., 2011; Volicer, 2017). Similarly, cholinergic systems are implicated, particularly given that antidepressant withdrawal can produce a syndrome of cholinergic overdrive with somatic distress and movement disorders (Dilsaver et al., 1987), and the central anticholinergic syndrome can present with confusion and agitation mimicking catatonic excitement (Cook & Spence, 1997).

In summary, the neuropharmacology of catatonia due to a medical condition is complex, reflecting the disruption of a delicate balance between inhibitory (GABA) and excitatory (glutamate) systems, profoundly modulated by dopamine and other monoamines. The specific nature of the underlying medical condition likely determines which system is primarily affected, leading to the heterogeneous clinical presentations of the syndrome.

## Genetic and Molecular Basis

While Catatonic Disorder Due to Another Medical Condition is, by definition, precipitated by a non-psychiatric illness, genetic factors may confer a vulnerability that increases the likelihood of developing catatonia when exposed to a medical or neurological stressor (Dodd, 2007; Meehl, 1989). The evidence for a genetic basis comes from several lines of research, including family and twin studies of associated primary psychiatric disorders, the identification of specific genetic syndromes that feature catatonic-like signs, and the discovery of gene variants that promote neuronal hyperexcitability (Dodd, 2007; Muniz et al., 2024).

### Heritability and Genetic Predisposition

The historical association between catatonia and schizophrenia provides an initial framework for considering genetic vulnerability (Dodd, 2007). Schizophrenia is a highly heritable disorder, with twin studies showing concordance rates of nearly 50% for monozygotic twins compared to 17% for dizygotic twins (Dodd, 2007). Family studies likewise show increased risk, with siblings of individuals with schizophrenia having a 10% chance of developing the illness (Dodd, 2007). While these figures pertain to schizophrenia broadly, they suggest that the underlying genetic liability for schizophrenia may also include a predisposition to developing catatonic features, particularly when the central nervous system is challenged by a medical illness. This aligns with the "two-hit" or "multiple-hit" hypothesis, which posits that a genetic predisposition (first hit) requires an additional environmental or medical stressor (second hit) to manifest clinically (Dodd, 2007). In this context, a severe medical condition could act as the second hit that unmasks a latent vulnerability for psychomotor dysregulation. Similarly, catatonia is frequently observed in severe mood disorders, which also have a strong genetic component (Takács & Rihmer, 2013; Perugi, 2010).

### Candidate Genes and Molecular Mechanisms

Recent research is beginning to move beyond broad heritability to identify specific genetic variants. A pivotal study identified neuropsychiatric genetic variants in individuals who developed catatonia and psychosis, suggesting that these variants may lead to a state of neuronal hyperexcitability that manifests as a catatonic syndrome when triggered (Muniz et al., 2024). This finding provides a direct molecular link between genetic predisposition and the clinical phenotype. The implicated genes may involve ion channels, synaptic proteins, or neurotransmitter systems, creating a state of altered neural network stability that is susceptible to decompensation under physiological stress (Söderpalm, 2002; Muniz et al., 2024).

Further evidence comes from the study of monogenic neurodevelopmental and neurodegenerative disorders where catatonic signs or related movement disorders are part of the core phenotype. For example, *STXBP1*-related encephalopathy is a genetic disorder characterized by refractory seizures, intellectual disability, and movement disorders such as ataxia and dystonia (Khaikin & Mercimek-Andrews, 2016). *ASXL3*-related disorder presents with intellectual disability, hypotonia that can transition to spasticity, and unusual posturing (Balasubramanian & Schirwani, 1993). Other syndromes, such as 7q11.23 duplication syndrome, are associated with adventitious movements (Mervis et al., 2015), while Trisomy 4p syndrome can involve hyperactivity and seizures (Gonzalez et al., 1977). Many genetic syndromes feature stereotypies and repetitive behaviors, which are also cardinal symptoms of catatonia (Murayama et al., 1991; Barry et al., 2011; Belardinelli & Raza, 2016). For instance, catatonic features like mutism, posturing, and agitation are increasingly recognized in individuals with autism spectrum disorder (ASD), a condition with a strong genetic basis (Dhossche et al., 2009; Chandel et al., 2023; Wang & Zhong, 2012). The overlap between catatonic signs and the motor abnormalities seen in these specific genetic conditions suggests that shared molecular pathways—perhaps involving synaptic function, neuronal development, or ion channel regulation—may underlie the vulnerability to psychomotor dysregulation.

The molecular mechanisms likely converge on the neurotransmitter systems discussed previously. Genes affecting dopamine receptors (D1-D5), transporters, or synthesis enzymes could alter dopaminergic tone in cortico-striatal circuits (Dodd, 2007). Similarly, variants in genes for GABA or glutamate receptors, or the enzymes involved in their synthesis and metabolism, could disrupt the fundamental excitatory-inhibitory balance of the brain (Söderpalm, 2002; Naguy, 2015). For example, mutations affecting the function of the glycine receptor have been identified in hyperekplexia, a nonepileptic startle disorder characterized by muscular rigidity, which shares features with catatonia (Hahn & Sanger, 2004; Chan et al., 2012). This highlights how a single molecular defect can produce a specific form of psychomotor abnormality. Autoimmune conditions provide another molecular link; in anti-NMDA receptor encephalitis, antibodies disrupt the function of a key glutamate receptor, leading directly to a syndrome that frequently includes catatonia (Bykov et al., 2024; Connell et al., 2022).

In conclusion, the genetic and molecular basis of catatonia due to another medical condition is likely multifactorial, involving a complex interplay between a polygenic predisposition to psychomotor instability and the specific molecular pathology of the precipitating medical illness (Dodd, 2007; Meehl, 1989). Specific genetic syndromes offer valuable models for understanding how disruptions in defined molecular pathways can produce catatonic-like signs, while emerging research on gene variants associated with neuronal hyperexcitability provides a more direct link between an individual's genetic makeup and their risk of developing catatonia in the face of a significant physiological stressor (Muniz et al., 2024).

## Brain Structure and Function

The diverse motor, affective, and behavioral symptoms of catatonia are the clinical expression of widespread dysfunction in cortico-subcortical neural circuits responsible for initiating and modulating behavior (Dodd, 2007; Nambu, 2012). Medical conditions precipitating catatonia often do so by causing structural or functional lesions within these critical networks (Neto, 2009; Connell et al., 2022). Neuroimaging and neuropathological studies have begun to map the anatomical substrates of this complex syndrome, pointing towards a final common pathway of disrupted communication between the frontal lobes, basal ganglia, thalamus, and limbic system (Dodd, 2007; Pontius, 1984).

### Brain Regions, Neural Circuits, and Functional Connectivity

A leading hypothesis posits that catatonia results from the disruption of frontal-subcortical circuits, particularly the cortico-striato-pallido-thalamo-cortical (CSPTC) loops that regulate motor, cognitive, and emotional functions (Nambu et al., 2014; Iacono, 2024). These loops are essential for selecting and initiating appropriate goal-directed actions while inhibiting competing, inappropriate ones (Frith, 1987; Spence, 2001).

**Frontal Lobes:** The prefrontal cortex, especially the orbitofrontal, dorsolateral, and medial regions, is consistently implicated (Dodd, 2007; Funayama, 2023). Functional neuroimaging studies in schizophrenia often reveal "hypofrontality," a state of reduced frontal lobe activity that is linked to negative symptoms like avolition and alogia, which overlap significantly with the retarded symptoms of catatonia (Dodd, 2007; Frith, 1987). Lesions in the medial frontal/anterior cingulate circuit can cause severe apathy and akinesia, mimicking catatonic stupor (Lévy, 2021; Heilman, 1976). The anterior cingulate cortex is crucial for motivation and transferring affective value to guide behavior (Lévy, 2021). Dysfunction here could explain the profound lack of initiative and emotional indifference seen in many catatonic patients (Caeiro et al., 2013). Conversely, orbitofrontal lesions can lead to disinhibition, impulsivity, and stereotyped behaviors, which may relate to the excited and repetitive features of catatonia (Jurado & Junqué, 2001; Funayama, 2023).

**Basal Ganglia:** As a central node in motor control loops, the basal ganglia (caudate, putamen, globus pallidus, subthalamic nucleus) are critically involved (Dodd, 2007; Nambu, 2012). Pathophysiological models of movement disorders propose that an imbalance between the "direct" and "indirect" pathways through the basal ganglia can lead to either hypokinetic (like parkinsonism) or hyperkinetic (like chorea) states (Nambu et al., 2014; Nambu, 2012). It is hypothesized that a similar imbalance could underlie the hypo- and hyperkinetic poles of catatonia (Dodd, 2007; Nambu, 2012). For example, excessive inhibitory output from the basal ganglia to the thalamus could produce the akinesia of retarded catatonia, while deficient output could release the motor system, resulting in the agitation of excited catatonia (Nambu et al., 2014). Medical conditions such as stroke, anoxia, or metabolic disorders that selectively damage the basal ganglia can precipitate movement disorders, including dystonia and parkinsonism, and also catatonia (Dodd, 2007; Dalvi et al., 2012).

**Thalamus:** The thalamus serves as a critical relay station, integrating inputs from the basal ganglia and cerebellum and projecting back to the cortex (Dodd, 2007; Wilson & Nashold, 1968). Thalamic lesions can produce a wide range of neuropsychiatric symptoms, including apathy, memory deficits, and movement disorders (Albert et al., 1974; Spinella, 2004). Disruption of thalamocortical projections can lead to a state of cortical inhibition or disorganization, contributing to the cognitive and motor signs of catatonia (Dodd, 2007). Some PET studies in schizophrenia have implicated the thalamus, particularly the dorsomedial nucleus, in the disease process (Dodd, 2007).

**Limbic System and Parietal Cortex:** The limbic system, including the amygdala and hippocampus, is crucial for emotional processing and memory (Dodd, 2007; Pontius, 1988). The profound fear, anxiety, or mood disturbances often associated with catatonia suggest limbic involvement (Takács & Rihmer, 2013). A case report of catatonia associated with a left temporal lesion and amygdala atrophy directly supports this link (Neto, 2009). Pontius (1984, 1993) has repeatedly proposed a "Limbic Psychotic Trigger Reaction," a seizure-like state stemming from a functional imbalance between limbic and frontal lobe systems, to explain sudden, out-of-character behaviors that overlap with catatonic excitement. The parietal cortex, especially the right inferior parietal lobe, is involved in spatial awareness, motor planning, and the sense of agency (Spence, 2001; Jenkinson et al., 2014). Lesions here can cause motor neglect, a failure to use a limb despite intact strength, which shares features with the akinesia and negativism of catatonia (Marshall et al., 2002; Torii, 1993; Heilman et al., 2000). The disturbed sense of volition in catatonia may relate to dysfunction in these parietal networks that monitor the relationship between intention and action (Haggard et al., 2003; Spence, 2002).

### Neuroimaging Findings

Neuroimaging provides in vivo evidence for the structural and functional brain abnormalities underlying catatonia. Although few studies have specifically imaged patients with catatonia due to a medical condition, findings from related disorders like schizophrenia are highly informative.

**Structural Neuroimaging:** The most consistent structural finding in schizophrenia is ventricular enlargement, particularly of the third and lateral ventricles, suggesting a loss of brain volume (Dodd, 2007). Selective reductions in the size of the frontal lobe, temporal lobe, basal ganglia, thalamus, and limbic structures like the hippocampus have also been reported (Dodd, 2007). These findings indicate that the very brain regions implicated in circuit-level models of catatonia are structurally compromised in a related disorder. Case reports provide more direct evidence; for instance, an MRI scan in a patient with catatonia revealed a right temporal medial lesion with amygdala atrophy, highlighting a specific structural correlate for the syndrome in that individual (Neto, 2009). Other structural abnormalities like partial callosal agenesis have also been noted with increased incidence (Dodd, 2007).

**Functional Neuroimaging:** Functional studies, such as positron emission tomography (PET), have provided further support for the circuit dysfunction model. "Hypofrontality," or reduced metabolic activity in the frontal and prefrontal cortex, is a common finding in schizophrenia, associated with negative symptoms and cognitive deficits that resemble catatonic signs (Dodd, 2007). PET studies have specifically implicated the orbital, dorsolateral, and medial frontal cortex, anterior cingulate gyrus, thalamus, and various temporal lobe subregions in the pathophysiology of psychosis (Dodd, 2007; Fletcher, 2003). Such functional deficits in key nodes of motor and emotional control circuits provide a compelling substrate for the clinical manifestations of catatonia. Future research using functional connectivity analyses will likely further elucidate how medical conditions disrupt the coordinated activity within and between these large-scale brain networks, leading to the profound psychomotor breakdown of catatonia.

## Developmental Neurobiology

The emergence of Catatonic Disorder Due to Another Medical Condition is not solely dependent on the acute medical insult but is also influenced by the brain's developmental trajectory and pre-existing vulnerabilities (Dodd, 2007; Meehl, 1989). A developmental neurobiology perspective suggests that early life events, genetic predispositions, and critical periods of brain maturation can create a latent susceptibility to psychomotor dysregulation, which may only become manifest when the central nervous system is later challenged by a significant physiological stressor (Dodd, 2007; Alderton, 1966). This framework is encapsulated by the "two-hit" or "multiple-hit" hypothesis, which is strongly supported in the context of schizophrenia and can be extended to understand catatonia (Dodd, 2007).

### The "Two-Hit" Hypothesis and Early Brain Insults

The "two-hit" model proposes that a primary, often prenatal or perinatal, disruption to brain development (the "first hit") establishes a silent vulnerability (Dodd, 2007). This vulnerability may not produce overt symptoms but renders the brain susceptible to the effects of a later, "second hit," such as a medical illness, substance use, or psychosocial stress, which then triggers the onset of the clinical disorder (Dodd, 2007; Ciompi, 1984).

The first hit can comprise a wide range of factors. Genetic predispositions, as discussed previously, are a major component (Dodd, 2007; Muniz et al., 2024). Additionally, a history of injury at birth, such as perinatal anoxia or trauma, may contribute significantly to the development of later psychiatric disorders (Dodd, 2007; Gonzalez et al., 1977). These early insults can disrupt critical neurodevelopmental processes like neuronal migration, synaptogenesis, and myelination, leading to subtle but permanent alterations in neural circuitry (Murayama et al., 1991; Lebedinskaia, 1980). A child with such a background may show delayed developmental milestones or awkwardness in motor skills, which can be seen as early, soft neurological signs of this underlying vulnerability (Dodd, 2007; Liptak, 1998). The observation that a higher proportion of individuals with schizophrenia are born in the winter or early spring has also been linked to a higher incidence of maternal viral infections during the second trimester, a critical period for cortical development, suggesting another potential "first hit" (Dodd, 2007).

When a severe medical condition—such as an infection, metabolic derangement, or stroke—occurs later in life, it acts as the "second hit." This new physiological stressor taxes the already compromised neural networks beyond their capacity for homeostatic regulation, leading to a breakdown in function that manifests as catatonia (Michelson et al., 1994; Brame & Singer, 2010).

### Catatonia in Neurodevelopmental Disorders

The strong association between catatonia and neurodevelopmental disorders, particularly autism spectrum disorder (ASD), provides compelling evidence for a developmental basis (Dhossche et al., 2009; Marazziti, 2003). Individuals with ASD have a significantly increased risk of developing catatonia, with some systematic reviews reporting features of catatonia in over 20% of this population (Chandel et al., 2023). The core features of ASD, such as impaired communication, social withdrawal, and repetitive, stereotyped movements, share considerable phenomenological overlap with catatonic signs like mutism, withdrawal, and stereotypies (Dhossche et al., 2009; Barry et al., 2011; Wang & Zhong, 2012). This symptomatic overlap suggests shared underlying neurobiological pathways, possibly involving fronto-striatal circuits and GABA/glutamate imbalances (Marazziti, 2003; Belardinelli & Raza, 2016).

In individuals with ASD, catatonia can emerge insidiously or be precipitated by a medical illness or psychosocial stressor (Chandel et al., 2023; Dhossche et al., 2009). The presence of a pre-existing neurodevelopmental disorder appears to lower the threshold for developing a catatonic state in response to such triggers. The underlying brain abnormalities in ASD—including altered synaptic pruning, abnormal connectivity, and cerebellar dysfunction—may create a state of chronic psychomotor instability (Marazziti, 2003; Iacono, 2024). When a medical condition introduces further physiological disruption, this fragile system can decompensate into a full-blown catatonic syndrome (Chandel et al., 2023). This is supported by genetic linkage studies suggesting a common genetic region on chromosome 15q for both autism and catatonia (Chandel et al., 2023).

Similarly, catatonic-like features are observed in a range of other genetic syndromes with neurodevelopmental consequences, such as Rett syndrome, Fragile X syndrome, and various chromosomal abnormalities (Wang & Zhong, 2012; Gonzalez et al., 1977; Murayama et al., 1991). These conditions, which involve known disruptions to brain development, serve as human models demonstrating how early developmental pathology creates a lifelong vulnerability to severe psychomotor disturbances, including catatonia (Hodapp, 1997). Therefore, when catatonia emerges in the context of a medical condition in an individual with a known neurodevelopmental disorder, it can be conceptualized as the clinical manifestation of a "second hit" on a developmentally vulnerable brain.

## Treatment Mechanisms

The treatment of Catatonic Disorder Due to Another Medical Condition is twofold: addressing the underlying medical etiology and providing specific symptomatic relief for the catatonic signs (Mohr, 2022; Connell et al., 2022). The remarkable efficacy of certain somatic therapies, particularly benzodiazepines and electroconvulsive therapy (ECT), provides crucial insights into the neurobiological mechanisms of the syndrome (Ogunlela & Raai, 2022; Fernandez-Robles et al., 2015). These interventions appear to directly target the core neurotransmitter and circuit-level dysfunctions that give rise to the catatonic state.

### Pharmacological Interventions

**Benzodiazepines:** High-dose benzodiazepines, such as lorazepam, are the established first-line treatment for catatonia, regardless of its cause (Ogunlela & Raai, 2022; Mohr, 2022). Their therapeutic effect is often rapid and dramatic, a phenomenon sometimes referred to as the "lorazepam challenge," which can be both diagnostic and therapeutic (Ogunlela & Raai, 2022). Benzodiazepines are positive allosteric modulators of the GABA-A receptor, enhancing the effect of the brain's primary inhibitory neurotransmitter, GABA (Söderpalm, 2002). The success of this treatment strongly supports the hypothesis that a state of profound GABAergic deficit, particularly within cortical and subcortical motor circuits, is a central pathophysiological mechanism in catatonia (Naguy, 2015). By restoring inhibitory tone, benzodiazepines are thought to quell the neuronal hyperexcitability and normalize the dysfunctional activity within frontal-subcortical loops that generate catatonic symptoms (Muniz et al., 2024). Medical conditions may precipitate catatonia by disrupting GABAergic function through various means, and benzodiazepines act to directly counteract this final common pathway.

**NMDA Receptor Antagonists:** Given the evidence for glutamatergic hyperactivity in some conditions causing catatonia (e.g., anti-NMDA receptor encephalitis), medications that antagonize the NMDA glutamate receptor are a logical therapeutic target (Bykov et al., 2024). The use of agents like amantadine and memantine has been explored for this purpose. A compelling case report documented the successful use of acamprosate, a drug with NMDA-antagonistic properties, to achieve a sustained response in a patient with catatonic frontotemporal dementia whose improvement with ECT was short-lived (Naguy, 2015). This suggests that in catatonia driven by glutamate excitotoxicity, directly modulating the glutamatergic system may be more effective or necessary for long-term stability than relying solely on enhancing GABAergic inhibition.

**Antipsychotics:** The role of antipsychotic medications is complex and controversial (Dodd, 2007). While atypical antipsychotics are sometimes used, particularly when psychotic symptoms are prominent, they must be administered with extreme caution (Dodd, 2007; Mohr, 2022). Dopamine D2 receptor antagonists, especially typical antipsychotics, can induce or exacerbate catatonic symptoms and carry the risk of precipitating the life-threatening neuroleptic malignant syndrome (NMS), which is clinically similar to malignant catatonia (Connell et al., 2022; Ogunlela & Raai, 2022). This adverse effect underscores the potential role of dopamine hypofunction in the pathophysiology of retarded catatonia. If an antipsychotic is deemed necessary, an atypical agent with lower D2 receptor affinity is generally preferred (Dodd, 2007).

### Electroconvulsive Therapy (ECT)

ECT is a highly effective and often life-saving treatment for catatonia, particularly for malignant forms or cases that are refractory to benzodiazepines (Fink, 2010; Shams et al., 2010; Connell et al., 2022). While historically considered a treatment for psychiatric disorders like depression and catatonic schizophrenia, its efficacy extends to catatonia arising from general medical conditions (Dodd, 2007; Rosebush & Mazurek, 2007). However, some evidence suggests that the response may be diminished when the catatonia is due to a chronic, underlying neurologic condition (Swartz et al., 2003).

The precise mechanism of ECT remains incompletely understood, but it is known to induce a generalized tonic-clonic seizure under controlled conditions (Dodd, 2007; MacDonald, 2002). This induced seizure is thought to produce widespread neurobiological changes. One leading hypothesis is that ECT acts as a powerful "reset" for dysfunctional brain circuits (Scholly et al., 2013). The massive, synchronous neuronal firing during the seizure may disrupt the pathological patterns of activity that sustain the catatonic state, allowing for the re-establishment of more normal functional connectivity (Alexander, 1953).

At the neurochemical level, ECT has been shown to cause significant alterations in multiple neurotransmitter systems. It can upregulate GABAergic function, enhance dopaminergic transmission, and modulate serotonergic and noradrenergic systems (Söderpalm, 2002). This broad neurochemical impact may explain its efficacy across a syndrome with heterogeneous underlying causes; by affecting multiple systems simultaneously, it can correct the specific imbalance driving the catatonia in a given patient. Furthermore, ECT is known to promote neuroplasticity and neurogenesis, particularly in the hippocampus, which may contribute to longer-term therapeutic effects beyond the acute resolution of catatonic signs (Pujol & Puel, 1999). In malignant catatonia, where profound autonomic dysregulation is a key feature, the powerful effect of ECT on central autonomic and neuroendocrine control centers may be critical in restoring homeostasis and preventing cardiovascular collapse (Connell et al., 2022; Rosebush & Mazurek, 2007).

In conclusion, the primary somatic treatments for catatonia directly target the posited neurobiological substrates of the disorder. Benzodiazepines restore inhibitory GABAergic tone, while ECT provides a more global and powerful intervention that resets pathological circuit activity and modulates multiple neurotransmitter systems. The effectiveness of these treatments provides strong convergent evidence for the underlying biological nature of the catatonic syndrome.

## Future Directions

Despite significant advances in recognizing catatonia as a distinct neuropsychiatric syndrome with diverse etiologies, our understanding of its underlying biology remains incomplete. The field is poised for substantial progress, driven by advances in neuroimaging, genetics, and systems neuroscience. Future research should prioritize several key areas to translate our growing knowledge into more precise diagnostics and targeted therapeutics for Catatonic Disorder Due to Another Medical Condition.

First, there is a critical need for studies that directly investigate the neurobiology of catatonia precipitated by specific medical conditions. Much of our current understanding is extrapolated from research on schizophrenia and mood disorders (Dodd, 2007; Takács & Rihmer, 2013). Prospective, longitudinal studies employing advanced neuroimaging techniques in patients who develop catatonia from etiologies such as autoimmune encephalitis, stroke, or metabolic derangements are essential. For example, using functional MRI (fMRI) and PET to compare the patterns of circuit dysfunction in catatonia secondary to anti-NMDA receptor encephalitis versus catatonia in a patient with a basal ganglia infarct could reveal both common final pathways and etiology-specific differences (Fletcher, 2003; Dodd, 2007). This would help to move beyond a generalized model of frontal-subcortical dysfunction to a more nuanced understanding of how different medical insults map onto the clinical phenotype.

Second, the genetic architecture of vulnerability to catatonia warrants deeper exploration. While links to schizophrenia liability genes provide a starting point (Dodd, 2007), the identification of variants that confer a specific risk for psychomotor dysregulation under physiological stress is a crucial next step (Muniz et al., 2024). Genome-wide association studies (GWAS) in large cohorts of patients with catatonia from various causes could identify novel risk loci. Furthermore, studying the genetics of individuals who develop catatonia after a specific medical insult (e.g., sepsis) compared to those who experience the same insult without catatonia could isolate key vulnerability genes related to neuronal excitability, immune response, or neuroendocrine regulation (Bykov et al., 2024; Michelson et al., 1994).

Third, the phenomenological heterogeneity of catatonia itself requires neurobiological dissection. The distinction between retarded (stuporous, akinetic) and excited (agitated) catatonia is fundamental, yet the circuit-level basis for this polarity is poorly understood (Rosebush & Mazurek, 2007; Devine, 1914). It is plausible that these subtypes reflect different primary neurotransmitter imbalances (e.g., GABA deficit vs. dopamine excess) or dysfunction in distinct neural circuits (e.g., medial frontal vs. orbitofrontal) (Dodd, 2007; Nambu, 2012). Research combining precise clinical phenotyping of individual catatonic signs (e.g., posturing, stereotypy, negativism) with functional neuroimaging could help map specific symptoms to specific circuit disruptions (Neto, 2009). This approach could explain why some patients exhibit a "pure" retarded picture while others show a mix of inhibitory and excitatory signs.

Fourth, the development of more robust animal models is crucial for mechanistic studies. While models of schizophrenia or stress exist (Nomura et al., 1989), models that specifically recapitulate the psychomotor signs of catatonia in response to a simulated medical insult are needed. Such models would allow for invasive investigations of cellular and synaptic function, and for the high-throughput screening of novel therapeutic compounds that are not possible in humans. For example, a model could be developed to test whether blocking specific inflammatory cytokines during a systemic infection prevents the development of catatonic-like behaviors, thereby linking the immune and nervous systems (Płytycz & Seljelid, 2002).

Finally, research into treatment mechanisms must continue. While we know that benzodiazepines and ECT are effective, we need to understand why some patients, particularly those with chronic neurological conditions, show a diminished response (Swartz et al., 2003). Identifying biomarkers that predict treatment response would be a major advance. For instance, cerebrospinal fluid analysis for markers of glutamatergic or GABAergic dysfunction, or specific fMRI connectivity patterns, might one day guide clinicians to choose between a benzodiazepine, an NMDA antagonist, or ECT as the optimal initial treatment for a particular patient (Naguy, 2015).

By pursuing these avenues of research, the field can move toward a biologically grounded classification of catatonia subtypes and a personalized medicine approach to treatment, ultimately demystifying this condition and improving care for those affected.

## Conclusion

Catatonic Disorder Due to Another Medical Condition is a profound neuropsychiatric syndrome that stands at the intersection of neurology, psychiatry, and general medicine. Once viewed through the narrow lens of schizophrenia, it is now understood as a final common pathway of severe psychomotor dysregulation that can be precipitated by a vast array of organic pathologies (Mohr, 2022; Elyasi, 2016). The biological and neurological evidence reviewed in this chapter converges on a model of widespread dysfunction in the brain's highest-order circuits for motor control, emotional regulation, and goal-directed behavior.

The core of this dysfunction appears to lie within the intricate cortico-striato-pallido-thalamo-cortical loops, with critical contributions from the limbic system, cerebellum, and parietal cortex (Dodd, 2007; Nambu et al., 2014; Pontius, 1984). Medical conditions, whether structural, metabolic, infectious, or toxic, can precipitate catatonia by disrupting the function of these networks at multiple levels. At the neurochemical level, a disruption in the delicate balance between GABAergic inhibition and glutamatergic excitation appears to be a key mechanism, a hypothesis strongly supported by the therapeutic efficacy of benzodiazepines and the presentation of catatonia in conditions like anti-NMDA receptor encephalitis (Ogunlela & Raai, 2022; Bykov et al., 2024). The dopaminergic system is also critically implicated, with both hypo- and hyper-dopaminergic states potentially contributing to the opposing poles of retarded and excited catatonia, respectively (Dodd, 2007; Rosebush & Mazurek, 2007).

Structural and functional neuroimaging studies, though often conducted in the context of primary psychiatric disorders, corroborate this circuit-level model by revealing abnormalities in the volume and activity of the frontal lobes, basal ganglia, thalamus, and limbic structures (Dodd, 2007; Neto, 2009). Furthermore, a developmental perspective, informed by the "two-hit" hypothesis and the high comorbidity with neurodevelopmental disorders like autism, suggests that pre-existing vulnerabilities in brain architecture and function can lower the threshold for decompensation into a catatonic state when faced with a subsequent medical stressor (Dodd, 2007; Dhossche et al., 2009). The identification of specific genetic variants that promote neuronal hyperexcitability is beginning to provide a molecular basis for this predisposition (Muniz et al., 2024).

The dramatic effectiveness of somatic treatments like ECT further reinforces the biological nature of catatonia, suggesting that powerful, global modulation of brain activity can reset the pathological network dynamics that sustain the syndrome (Fink, 2010; Fernandez-Robles et al., 2015). In conclusion, Catatonic Disorder Due to Another Medical Condition is not a manifestation of a single disease process but rather a complex, heterogeneous syndrome representing a severe failure of brain integration. The diverse clinical signs—from mutism and stupor to purposeless excitement—are the outward expression of this internal neural collapse. A comprehensive understanding of the underlying neurobiological mechanisms is not only essential for accurate diagnosis and for differentiating it from mimics, but also provides a rational basis for treatment. Continued research into the specific circuits, neurotransmitters, and genetic factors involved will be paramount to developing more targeted and effective interventions, ultimately improving the prognosis for patients with this severe and life-threatening condition.

## References

1. Ab, S., & Lobanova, V. M. (2022). On the problem of the catatonic disorders taxonomy. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1994
2. Abdelrasheed, N. S. G., & Almajali, D. M. M. M. (2024). Non-Adaptive Defense Mechanisms and Their Relationship to Psychosomatic Disorders among a Sample of University Students. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.872
3. Adi, Y., Ashcroft, D. M., Browne, K. D., Beech, A. R., Fry-Smith, A., & Hyde, C. (2002). Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders. Health Technology Assessment. https://doi.org/10.3310/hta6280
4. Ae, L., & NIa, I. (1980). [Medical-psychologic study of somatic patients].. PubMed.
5. Aggarwal, A., Gracy, S., Gaurav, S., & Rajan, D. (2024). An Ayurveda Case Study on GTCS w.s.r to Apasmara Roga. AYUSHDHARA. https://doi.org/10.47070/ayushdhara.v11i2.1472
6. Albert, M. L., Feldman, R. G., & Willis, A. (1974). The `subcortical dementia' of progressive supranuclear palsy. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.37.2.121
7. Alderton, H. R. (1966). A Review of Schizophrenia in Childhood. Canadian Psychiatric Association Journal. https://doi.org/10.1177/070674376601100403
8. Alexander, L. (1953). THE EFFECT OF ELECTROSHOCK ON A "NORMAL" PERSON UNDER RECENT STRESS. American Journal of Psychiatry. https://doi.org/10.1176/ajp.109.9.696
9. Ali, A. M., Al‐Dossary, S. A., Laranjeira, C., Atout, M., Khatatbeh, H., Selim, A., Alkhamees, A. A., Aljaberi, M. A., Pakai, A., & Al‐Dwaikat, T. (2024). Cardiometabolic Morbidity (Obesity and Hypertension) in PTSD: A Preliminary Investigation of the Validity of Two Structures of the Impact of Event Scale-Revised. Journal of Clinical Medicine. https://doi.org/10.3390/jcm13206045
10. Antoniuk, S. A. (2013). [Non-epileptic disorders in infancy and adolescence].. PubMed.
11. Antón, R., Conde, L. A., Gardeazábal, M. B., Ozcariz, P. A., Zariquiey, N. C., Figueiredo, N. D. S., & Salinas, V. F. (2021). Cycloid psychosis. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.1702
12. Araújo, F., Almeida, T. F. D., Rodrigues, J. D., Venâncio, Â., Horta, A., & Lapa, G. (2013). 1963 – Difficulty in the psychopharmacological approach of fronto-temporal dementia- case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)76903-7
13. Arens, C., & Schwemmle, C. (2022). ["Ear rage": misophonia : Review and current state of knowledge]..
14. Arroyo, H., Klipstein, K., Ernst, C. L., & Finkel, J. H. (2016). Somatic Symptom and Related Disorders, Including Illness Anxiety, Factitious, Malingering, and Conversion Disorders. https://doi.org/10.1002/9781118654231.ch20
15. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2013). Nonconvulsive status epilepticus and psychotic symptoms: case report.. PubMed. https://doi.org/10.1708/1292.14295
16. Autor, R. N. C. M., Principal, C. A. V. S. T., Adjunta, G. C. L. T., & Externa, S. S. R. T. (2017). Interacción del estrés, empatía, satisfacción y fatiga en médicos de Urgencias.
17. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
18. Balasubramanian, M., & Schirwani, S. (1993). ASXL3-Related Disorder.
19. Ballard, C., O’Brien, J. T., James, I. A., & Swann, A. (2001). Management of other behavioural and psychological symptoms in dementia. https://doi.org/10.1093/oso/9780192631756.003.0019
20. Barnes, T. R. E., & Paton, C. (2011). Do antidepressants improve negative symptoms in schizophrenia?. BMJ. https://doi.org/10.1136/bmj.d3371
21. Barnhill, J. W., Okuda, M., Simpson, H. B., Stein, D. J., Simpson, H. B., Phillips, K. A., Phillips, K. A., Mataix‐Cols, D., Cruz, L. F. D. L., & Stein, D. J. (2023). Obsessive-Compulsive and Related Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615375295.jb06
22. Barry, S., Baird, G., Lascelles, K., Bunton, P., & Hedderly, T. (2011). Neurodevelopmental movement disorders - an update on childhood motor stereotypies. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.04058.x
23. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
24. Becker, C. B. (2010). Bulimia Nervosa. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0146
25. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
26. Belardinelli, C., & Raza, M. (2016). Comorbid Behavioral Problems and Psychiatric Disorders in Autism Spectrum Disorders. Journal of Childhood & Developmental Disorders. https://doi.org/10.4172/2472-1786.100011
27. Belardinelli, C., & Raza, M. (2016). Comorbid Behavioral Problems and Psychiatric Disorders in Autism Spectrum Disorders. Journal of Childhood & Developmental Disorders. https://doi.org/10.4172/2472-1786.100019
28. Berastegui, C., Monfort, E., & Boudin, B. (2017). Vocally disruptive behaviors management in older people with dementia. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2017.0657
29. Berger, M., & Sachs, A. (1953). PERCEPTIVE DEAFNESS ASSOCIATED WITH PROPHYLACTIC USE OF TETANUS ANTITOXIN. Archives of Otolaryngology - Head and Neck Surgery. https://doi.org/10.1001/archotol.1953.00710030524003
30. Berliana, M. C., Razzaq, A., & Jannati, Z. (2023). Penerapan Konseling Individu Dengan Teknik Cognitive Restructuring Untuk Mengatasi Post Traumatic Stress Disorder. Journal of Society Counseling.. https://doi.org/10.59388/josc.v1i2.239
31. Berlín, C. I. (1998). Auditory neuropathy. Current Opinion in Otolaryngology & Head & Neck Surgery. https://doi.org/10.1097/00020840-199810000-00008
32. Berry‐Kravis, E., Abrams, L., Coffey, S. M., Hall, D. A., Greco, C., Gane, L. W., Grigsby, J., Bourgeois, J. A., Finucane, B., Jacquemont, S., Brunberg, J. A., Zhang, L., Lin, J., Tassone, F., Hagerman, P. J., Hagerman, R. J., & Leehey, M. A. (2007). Fragile X‐associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines. Movement Disorders. https://doi.org/10.1002/mds.21493
33. Bezerra, E. D. L., & Zimmermann, M. (2015). DISTÚRBIOS COMPORTAMENTAIS EM CÃES: Ansiedade por Separação.
34. Bhatt, J. V. (2014). Stress physiology and impact of stress on coronary atherosclerotic heart diseases. Indian journal of applied basic medical sciences.
35. Bidaki, R., Safapour, P., Seyedchi, E., & Sorbi, M. H. (2016). Post-Partum Psychosis: Cultural Issue and Therapeutic Barriers and Regional Therapists. Journal of Advance Research in Pharmacy & Biological Science (ISSN 2208-2360). https://doi.org/10.53555/nnpbs.v2i4.711
36. Bie, R. M. A. D., & Holter, S. E. M. T. (2016). “She Is So Fidgety”. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190607555.003.0023
37. Black, D. W. (1982). Pathological laughter. A review of the literature.. PubMed.
38. Black, D. W. (1982). Pathological Laughter. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-198202000-00001
39. Bleuse, S. (2004). Effet de l'âge et de la maladie de Parkinson sur les ajustements posturaux anticipateurs lors d'un mouvement d'antéflexion du bras.
40. Bohnen, N. I., Kotagal, V., Albin, R. L., & Müller, M. L. (2014). The Effects of Salsa Dance on Gait and Balance in Multiple Sclerosis (P3.053). Neurology. https://doi.org/10.1212/wnl.0000000000000607
41. Bonamonte, D., Foti, C., Marco, A. D., Hansel, K., Cecchini, E., Filoni, A., Prezzo, S. D., Ambrogio, F., Angelini, G. D., & Stingeni, L. (2022). Self-inflicted pathological cutaneous disorders. Part II. Italian Journal of Dermatology and Venereology. https://doi.org/10.23736/s2784-8671.22.07376-5
42. Bouchard, S., Robillard, G., Larouche, S., & Loranger, C. (2012). Description of a Treatment Manual for in virtuo Exposure with Specific Phobia. InTech eBooks. https://doi.org/10.5772/46417
43. Boudjarane, M., Grandgeorge, M., Larrieu, C., & Lemonnier, É. (2015). Effet d’un traitement médicamenteux chez des enfants autistes : aspects cognitifs et neurosensoriels. HAL (Le Centre pour la Communication Scientifique Directe).
44. Brame, A., & Singer, M. (2010). Stressing the obvious? An allostatic look at critical illness. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e3181f23e92
45. Brewin, C. R. (2022). Identity – A critical but neglected construct in cognitive-behaviour therapy. Journal of Behavior Therapy and Experimental Psychiatry. https://doi.org/10.1016/j.jbtep.2022.101808
46. Brignole, M., Alboni, P., Benditt, D. G., Bergfeldt, L., Blanc, J., Thomsen, P. E. B., Dijk, J. G. V., Fitzpatrick, A., Hohnloser, S. H., Janousek, J., Kapoor, W. N., Kenny, R. A., Kułakowski, P., Masotti, G., Moyá, A., Raviele, A., Sutton, R., Theodorakis, G., Ungar, A., & Wieling, W. (2004). Guidelines on Management (diagnosis and treatment) of syncope ? update 2004. EP Europace. https://doi.org/10.1016/j.eupc.2004.08.008
47. Britton, J. W., Moseley, B. D., & Benarroch, E. E. (2014). Syncope and Other Causes of Transient Loss of Consciousness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199920198.003.0009
48. Brooks, C. N., Talmage, J. B., & Mueller, K. L. (2012). Subjective, Objective, or Both?. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2012.marapr02
49. Brust, J. C. (2001). Music and the Neurologist. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2001.tb05730.x
50. Brüne, M. (2015). Depressive disorders. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780198717942.003.0010
51. Brüne, M. (2015). Forensic aspects of psychiatric disorders. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780198717942.003.0021
52. Brüne, M. (2015). Obsessive-compulsive and related disorders. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780198717942.003.0012
53. Brüne, M. (2015). Schizophrenia spectrum and other psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780198717942.003.0008
54. Burnett, M. S. (2015). Hyperkinetic Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244927.003.0027
55. Bykov, Y. V., Bykova, A. Y., & Bekker, R. A. (2024). Autoimmune mediated suicidal behavior. Russian Journal of Immunology. https://doi.org/10.46235/1028-7221-16588-ams
56. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Post-Stroke Apathy: An Exploratory Longitudinal Study. Cerebrovascular Diseases. https://doi.org/10.1159/000350202
57. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Supplementary Material for: Post-Stroke Apathy: An Exploratory Longitudinal Study. Figshare. https://doi.org/10.6084/m9.figshare.5124829
58. Cagnin, A., Formentin, C., Pompanin, S., Zarantonello, G., Jelcic, N., Venneri, A., & Ermani, M. (2014). Simple motor stereotypies are not specific features of behavioural frontotemporal dementia. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2013-307471
59. Calle-Cruz, L. F. (2021). Primary health care services with diagnosis of tumor asthenia. International Journal of School and Cognitive Psychology.
60. Campos-Contreras, J., Lucío, P., Ramírez, T., Salazar, J. T., Espinosa, A. R., Marín, C., Silvestre, J. L., Velázquez, E. A., Salcedo, J. C., Bouthillier, P., & Pérez, E. R. (2007). Hiperactividad pélvica: diagnóstico y tratamiento en el Hospital Central Militar.
61. Candura, S. M., & Scelsi, R. (2013). [Occupational toxic neuropathies: morphology in peripheral nerve biopsies].. PubMed.
62. Cangi, F., Boccuni, M., Fusco, B. M., Curradi, C., & Sicuteri, F. (1987). Pentazocine in Migraine: Subjective and Pupillary Abnormal Effects. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.1987.hed2709503.x
63. Cano‐Vindel, A., Miguel-Tobal, J. J., González, H. M., & Díez, I. I. (1994). El afrontamiento de la ansiedad en las drogodependencias. Anales de Psicología.
64. Chan, K. K., Cherk, S. W.-W., Lee, H. H., Poon, W. T., & Chan, A. Y. (2012). Hyperekplexia. Journal of Child Neurology. https://doi.org/10.1177/0883073812465338
65. Chandel, S., Choudhary, S., & Sandhu, V. K. (2023). Recurrent catatonia in a patient with Schizophrenia and autism spectrum disorder. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_247_23
66. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
67. Chaudhry, N., Puri, V., Patidar, Y., & Khwaja, G. A. (2012). Pathological laughter associated with paroxysmal kinesigenic dyskinesia: A rare presentation of acute disseminated encephalomyelitis. Epilepsy & Behavior Case Reports. https://doi.org/10.1016/j.ebcr.2012.11.001
68. Cheshire, W. P. (2012). Alien Hand Syndrome: Ethical Issues. Encyclopedia of Life Sciences. https://doi.org/10.1002/9780470015902.a0024158
69. Ching, S., Westover, M. B., Shafi, M., Cash, S. S., & Brown, E. N. (2015). Real-time segmentation and tracking of brain metabolic state in ICU EEG recordings of burst suppression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139941433.015
70. Ciompi, L. (1984). Is there really a Schizophrenia? The Long-term Course of Psychotic Phenomena∗. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.145.6.636
71. Clark, H. B. (2024). Degenerative ataxic disorders. CRC Press eBooks. https://doi.org/10.1201/9781003389699-28
72. Colán, T. C., Gálvez, G. A., & Zevallos, D. C. (2013). Síntomas psiquiátricos e insulinoma: reporte de caso Psychiatric symptoms and insulinoma: a case report.
73. Colón, E. A., Popkin, M. K., & Carlson, B. E. (1989). Non-erotic self-choking in five psychiatric inpatients.. PubMed.
74. Connell, J., Oldham, M., Pandharipande, P. P., Dittus, R. S., Wilson, A. M., Mart, M. F., Heckers, S., Ely, E. W., & Wilson, J. E. (2022). Malignant Catatonia: A Review for the Intensivist. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666221114303
75. Cook, B. A., & Spence, A. (1997). Post-operative central anticholinergic syndrome. European Journal of Anaesthesiology. https://doi.org/10.1097/00003643-199701000-00001
76. Cope, T., & Baguley, D. (2009). Is musical hallucination an otological phenomenon? a review of the literature. Clinical Otolaryngology. https://doi.org/10.1111/j.1749-4486.2009.02013.x
77. Cornejo, W., Ortiz, B. R., & Blazicevich, L. (2012). Epidemiology of Tics. InTech eBooks. https://doi.org/10.5772/32426
78. Corrêa, C. R. G. L. (2013). Attention – Deficit Hyperactivity Disorder (ADHD) in Psychiatry and Psychoanalysis. InTech eBooks. https://doi.org/10.5772/52880
79. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
80. Custodio, N., Castro, S., Herrera‐Pérez, E., Lira, D., Prado, L. N. D., Cortijo, P., & Montesinos, R. (2013). Afasias progresivas primarias: las afasias de lenta evolución a demencia.. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v75i3.1227
81. Dahlem, M. A., Mair, T., & Müller, S. C. (2004). Spatio-Temporal Aspects of a Dynamical Disease: Waves of Spreading Depression. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7895-1_42
82. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
83. Dampney, R. (2011). The Hypothalamus and Autonomic Regulation: An Overview. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780195306637.003.0003
84. Dang, M. T. (2024). What Is a Good Approach to Thinking About a Child With Multiple Dysmorphisms?. CRC Press eBooks. https://doi.org/10.1201/9781003523659-56
85. Daum, I., & Ackermann, H. (1997). Nondeklaratives Gedächtnis - neuropsychologische Befunde und neuroanatomische Grundlagen. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2007-996316
86. Delgado, D. A. O., Rojas, M. C. O., & Olea, J. M. S. (2024). Episodio depresivo mayor de características catatónicas: Reporte de caso. Revista Científica de Salud y Desarrollo Humano. https://doi.org/10.61368/r.s.d.h.v5i1.75
87. Derbyshire, S., & Bremner, J. D. (2009). Impact Of Functional Visceral And Somatic Pain/Stress Syndromes On Cingulate Cortex. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566960.003.0023
88. Devine, H. (1914). The Clinical Significance of Katatonic Symptoms. Journal of Mental Science. https://doi.org/10.1192/bjp.60.249.278
89. Devinsky, O., & Vázquez, B. (1993). Behavioral Changes Associated with Epilepsy. Neurologic Clinics. https://doi.org/10.1016/s0733-8619(18)30173-7
90. Dhakal, A. K., Divya, K. C., Shrestha, D., Acharya, S., & Neupane, N. (2023). Abdominal Wall Dyskinesia in a Child Presenting as Belly Dancers’ Syndrome: A Case Report. Journal of Nepal Medical Association. https://doi.org/10.31729/jnma.8296
91. Dhossche, D. M., Reti, I. M., & Wachtel, L. E. (2009). Catatonia and Autism. Journal of Ect. https://doi.org/10.1097/yct.0b013e3181957363
92. Dhossche, D. M., Reti, I. M., Shettar, S. M., & Wachtel, L. E. (2010). Tics as Signs of Catatonia. Journal of Ect. https://doi.org/10.1097/yct.0b013e3181cb5f60
93. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
94. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
95. Dragoș, D., & Tănăsescu (2009). The critical role of psychosomatics in promoting a new perspective upon health and disease.. Journal of Medicine and Life.
96. Dragoș, D., Ionescu, O.-P., Micuţ, R., Ojog, D. G., & Tănăsescu, M. D. (2012). Psychoemotional features of a doubtful disorder: functional dyspepsia.. PubMed.
97. Dresler, T., Lürding, R., Paelecke–Habermann, Y., Gaul, C., Henkel, K., Lindwurm-Späth, A., Leinisch, E., & Jürgens, T. (2012). Cluster headache and neuropsychological functioning. Cephalalgia. https://doi.org/10.1177/0333102412449931
98. Drinkhill, M. J., Rivera, M. C., & Hainsworth, R. (2013). Autonomic function at high altitudes. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198566342.003.0017
99. Driver, J., & Vuilleumier, P. (2001). Unconscious Processing in Neglect and Extinction. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198506300.003.0007
100. Dwyer, C. M., & Bornett, H. L. I. (2004). Chronic stress in sheep: assessment tools and their use in different management conditions. Animal Welfare. https://doi.org/10.1017/s0962728600028402
101. Eapen, V., Moriarty, J., & Robertson, M. M. (1994). Stimulus induced behaviours in Tourette's syndrome.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.57.7.853
102. eGuile, J. M. (2014). Probabilistic Perception, Empathy, and Dynamic Homeostasis: Insights in Autism Spectrum Disorders and Conduct Disorders. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2014.00004
103. Einspieler, C., Peharz, R., & Marschik, P. B. (2016). Fidgety movements – tiny in appearance, but huge in impact. Jornal de Pediatria. https://doi.org/10.1016/j.jped.2015.12.003
104. Eisinger, J. (2001). Seven Steps to Fibromyalgia. Journal of Musculoskeletal Pain. https://doi.org/10.1300/j094v09n03_11
105. Eldeib, S., Damodaran, J., Wahba, A. A., Khayal, A., Attia, M. F., Elbermeshty, A., Khalloof, A., & Mousa, H. (2023). None. International Journal of Clinical Studies and Medical Case Reports. https://doi.org/10.46998/ijcmcr.26.5
106. Ellis, C. (2012). Autogenic reactions : peripheralia. South African Family Practice.
107. Elyasi, F. (2016). Catatonia: extinct, lost, or forgotten?. Journal of Emergency Practice and Trauma. https://doi.org/10.15171/jept.2016.02
108. Enticott, P. G., Upton, D. J., Bradshaw, J. L., Bellgrove, M. A., & Ogloff, J. R. P. (2011). Stop task after-effects in schizophrenia: Behavioral control adjustments and repetition priming. Neurocase. https://doi.org/10.1080/13554794.2011.627339
109. Espay, A. J., Fox, S. H., Marras, C., Lang, A. E., & Chen, R. (2007). Isolated diaphragmatic tremor. Neurology. https://doi.org/10.1212/01.wnl.0000267431.16316.69
110. Etemadifar, M., Abtahi, S., Abtahi, S.-M., Mirdamadi, M., Sajjadi, S., Golabbakhsh, A., Savoj, M.-R., Fereidan-Esfahani, M., Nasr, Z., & Tabrizi, N. (2012). Hemiballismus, Hyperphagia, and Behavioral Changes following Subthalamic Infarct. Case Reports in Medicine. https://doi.org/10.1155/2012/768580
111. Fahn, S., Greene, P., Ford, B., & Bressman, S. (2003). Movement Disorders. https://doi.org/10.1007/978-1-4757-4552-8_9
112. Fama, J. M., & Wilhelm, S. (2010). Obsessions. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0616
113. Fatigoni, S., Fumi, G., & Roila, F. (2015). [Cancer-related fatigue].. PubMed. https://doi.org/10.1701/1740.18954
114. Ferguson, E., & Cassaday, H. J. (2001). Theoretical Accounts of Gulf War Syndrome: From Environmental Toxins to Psychoneuroimmunology and Neurodegeneration. Behavioural Neurology. https://doi.org/10.1155/2002/418758
115. Fernandez-Robles, C., Beach, S. R., & Fricchione, G. L. (2015). Somatic Therapies in the Treatment of Catatonia. Future Neurology. https://doi.org/10.2217/fnl.15.32
116. Fernández‐Álvarez, E. (2015). Polymorphic, Benign, Nonepileptic, Paroxysmal, Infantile Movements (Fejerman Condition). Journal of Pediatric Neurology. https://doi.org/10.1055/s-0035-1563383
117. Fine, L., Dubrovsky, B., & Spielman, A. J. (2011). Insomnia. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805153311101010137
118. Fink, M. (2010). Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0011
119. Fletcher, P. C. (2003). Functional neuroimaging of schizophrenia: from a genetic predisposition to the emergence of symptoms. Brain. https://doi.org/10.1093/brain/awh113
120. Folkow, B. R. (1993). Pathophysiology of hypertension. Journal of Hypertension. https://doi.org/10.1097/00004872-199306003-00006
121. Fontalba-Navas, A., & Caparros-del-Moral, I. (2015). New Approaches to Psychotic Agitation: Staccato Loxapine. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30809-9
122. Forcén, F. E. (2015). Akathisia: Is Restlessness a Primary Condition or an Adverse Drug Effect? Keep a Discerning Eye out for This Adverse Effect of Antipsychotics and Other Drugs. Current psychiatry.
123. Ford, C. V. (1997). Somatic symptoms, somatization, and traumatic stress: An overview. Nordic Journal of Psychiatry. https://doi.org/10.3109/08039489709109078
124. Foxx–Orenstein, A. E. (2016). New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756283x16633050
125. Franco, J. J. D. (2007). Estrés alimentario y salud laboral vs. estrés laboral y alimentación equilibrada. Medicina y Seguridad del Trabajo. https://doi.org/10.4321/s0465-546x2007000400012
126. Franco, J. P., & Silva, C. (2012). Trastorno orgánico de personalidad: un diagnóstico desestimado en pacientes traumatizados de cráneo. Revista chilena de neuropsicología. https://doi.org/10.5839/rcnp.2012.0702.04
127. Frith, C. (1987). The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychological Medicine. https://doi.org/10.1017/s0033291700025873
128. Frock, B., Williams, A., & Caplan, J. P. (2016). Pseudobulbar Affect: When Patients Laugh or Cry, but Don't Know Why. Current psychiatry.
129. Fu, Q., & Levine, B. D. (2010). EDITORIAL: Why do young women (donors) faint?. Transfusion. https://doi.org/10.1111/j.1537-2995.2010.02593.x
130. Funayama, M. (2023). Potential Backgrounds Behind the Simultaneous Presence of Behavioral Changes and Spontaneous Confabulation after Orbitofrontal / ventromedial Prefrontal Cortex Injury. Higher Brain Function Research. https://doi.org/10.2496/hbfr.43.172
131. Gangloff, S. C., Cornu, J., & Guyot, J. C. (1997). Instability and Manipulation. Journal of Orthopaedic Medicine. https://doi.org/10.1080/1355297x.1997.11719839
132. Ganos, C., Mencacci, N. E., Gardiner, A., Erro, R., Batla, A., Houlden, H., & Bhatia, K. P. (2014). Paroxysmal Kinesigenic Dyskinesia May Be Misdiagnosed in Co-occurring Gilles de la Tourette Syndrome. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12001
133. Garozzo, M. T., Caruso, D., Mendola, F. M. C. L., Nora, A. D., Romano, K., Leonardi, R., Falsaperla, R., Zanghì, A., & Praticò, A. D. (2021). SYNGAP1 and Its Related Epileptic Syndromes. Journal of Pediatric Neurology. https://doi.org/10.1055/s-0041-1727144
134. Geiser, M., Good, J., & Guinchat, V. (2024). Pregabalin treatment in a 30-year-old patient with Bainbridge-Ropers syndrome: a case-report. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2024.1502773
135. Gentileschi, V., Sperber, S., & Spinnler, H. (2001). C ROSSMODAL AGNOSIA FOR FAMILIAR PEOPLE AS A CONSEQUENCE OF RIGHT INFERO POLAR TEMPORAL ATROPHY. Cognitive Neuropsychology. https://doi.org/10.1080/02643290125835
136. Gewandter, J. S., Dworkin, R. H., Finnerup, N. B., & Mohile, N. (2016). Painful chemotherapy-induced peripheral neuropathy: lack of treatment efficacy or the wrong clinical trial methodology?. Pain. https://doi.org/10.1097/j.pain.0000000000000653
137. Ghasemian, D., D’Souza, L., & Ebrahimi, S. (2012). Effectiveness of Rational Emotive Behaviour Therapy on Shyness: Influence of Age. JOURNAL OF PSYCHOSOCIAL RESEARCH.
138. Ghika, J., Diéguez, S., Assal, F., & Démonet, J. (2013). [Mirror behaviors in dementia: the many mirror signs].. PubMed.
139. Gillen, M., Rose, E., & Schwarze, J. (2014). Conduct Disorder. https://doi.org/10.63134/nbfb7032
140. Gold, B. G., Schnell, J. V., & Spencer, P. S. (2003). Neurotoxic Disorders. https://doi.org/10.1007/978-1-4757-4552-8_14
141. Goldman, S. (2003). Neurogenic Positional Pedal Neuritis. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/87507315-93-3-174
142. Goldman, S. (2013). The Professor Position and the Single-Stance Flexion Test May Clarify the Effect of Lumbar Spinal Stenosis or Pseudostenosis on Lower-Extremity Symptoms. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/1030156
143. Gomathy, S. B., Saini, A., Gupta, A., Vishnu, V. Y., Singh, M. B., Bhatia, R., Srivastava, M. P., Radhakrishnan, D. M., Srivastava, A. K., & Rajan, R. (2024). A rare yet treatable case of paroxysmal kinesigenic dyskinesia. Annals of Movement Disorders. https://doi.org/10.4103/aomd.aomd_28_23
144. Gonzalez, C. H., Sommer, A., Meisner, L. F., Elejalde, B. R., Opitz, J. M., & Francke, U. (1977). The trisomy 4p syndrome: Case report and review. American Journal of Medical Genetics. https://doi.org/10.1002/ajmg.1320010202
145. Gorman, W. F. (1982). Defining malingering.. PubMed.
146. Greden, J. F., Dilsaver, S. C., & Snider, R. M. (1987). Antidepressant Withdrawal Syndromes: Phenomenology and Pathophysiology. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-198701000-00001
147. Gresty, M. A., & Ohlmann, T. (2003). Motorists Vestibular Disorientation Syndrome Revisited.
148. Grimmer, K., Larsen, T. M., & Kumar, S. (2004). Effectiveness of manipulation and mobilisation for headaches: an evidence-based systematic review. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2004-665
149. Grosso, S., Cioni, M., Pucci, L., Morgese, G., & Balestri, P. (1999). Selective mutism, speech delay, dysmorphisms, and deletion of the short arm of chromosome 18: a distinct entity?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.67.6.830
150. Guedj, M.-J. (2003). [Emergency situations in psychiatry].. PubMed.
151. Gupta, P., Borasi, M., & Maggu, G. (2022). Abstract- Poster. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.341995
152. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
153. Gómez‐Tortosa, E., Rigual, R., Prieto-Jurczynska, C., Mahíllo, I., Guerrero, R., Pérez‐Pérez, J., & Sainz, M. J. (2015). Behavioral Evolution of Progressive Semantic Aphasia in Comparison with Nonfluent Aphasia. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000439521
154. Haggard, P., Martin, F., Taylor-Clarke, M., Jeannerod, M., & Franck, N. (2003). Awareness of action in schizophrenia. Neuroreport. https://doi.org/10.1097/00001756-200305230-00035
155. Hahn, J. S., & Sanger, T. D. (2004). Neonatal Movement Disorders. NeoReviews. https://doi.org/10.1542/neo.5-8-e321
156. Halbauer, J. D., Ashford, J. W., Zeitzer, J. M., Adamson, M. M., Lew, H. L., & Yesavage, J. A. (2009). Neuropsychiatric diagnosis and management of chronic sequelae of war-related mild to moderate traumatic brain injury. The Journal of Rehabilitation Research and Development. https://doi.org/10.1682/jrrd.2008.08.0119
157. Hartanto, H., Hartono, B., & Nathawira, K. M. (2022). Sikap Berdiri Lama Dalam Menimbulkan Nyeri Punggung Bawah. Jurnal MedScientiae. https://doi.org/10.36452/jmedscientiae.v1i2.2661
158. He, R. (1976). The direction of apparent movement during transient pressure vertigo.. PubMed.
159. Hebbar, S. (2013). Cognitive Therapy of Obsessive Compulsive Disorder with Chronic Tic Disorder. Indian Journal of Psychological Medicine. https://doi.org/10.4103/0253-7176.112216
160. Heilman, K. M. (1976). Exploring the enigmas of frontal lobe dysfunction.. PubMed.
161. Heilman, K. M. (2016). A Brief History of Upper Limb Ideomotor Apraxia. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199765683.013.3
162. Heilman, K. M., Valenstein, E., & Watson, R. T. (2000). Neglect and Related Disorders. Seminars in Neurology. https://doi.org/10.1055/s-2000-13179
163. Heilman, K. M., Watson, R. T., & Valenstein, E. (2003). Neglect and Related Disorders. https://doi.org/10.1093/oso/9780195133677.003.0013
164. Henry, J. A., Theodoroff, S. M., Edmonds, C. M., Martinez, I., Myers, P. J., Zaugg, T. L., & Goodworth, M.-C. (2022). Sound Tolerance Conditions (Hyperacusis, Misophonia, Noise Sensitivity, and Phonophobia): Definitions and Clinical Management. American Journal of Audiology. https://doi.org/10.1044/2022_aja-22-00035
165. Henry, J. L., & Wilson, P. H. (2001). The psychological management of chronic tinnitus : a cognitive-behavioral approach. Allyn and Bacon eBooks.
166. Hernández, M., ESQUIVEL, N., & López, M. (2014). Fisiopatología, diagnóstico diferencial y tratamiento de la apnea emotiva grave: A propósito de un caso clínico. Revista chilena de pediatría. https://doi.org/10.4067/s0370-41062014000400012
167. Hernández-Porras, B. C., Plancarte, R., Alarcón-Barrios, S., & Sámano-García, M. (2016). Síndrome doloroso regional complejo: revisión. Cirugía y Cirujanos. https://doi.org/10.1016/j.circir.2016.11.004
168. Herpertz, S. C., & Saß, H. (2000). Emotional deficiency and psychopathy. Behavioral Sciences & the Law. https://doi.org/10.1002/1099-0798(200010)18:5<567::aid-bsl410>3.0.co;2-8
169. Hiraiwa, H., Hiraiwa, R., DATE, S., & Sakiyama, T. (2010). Muscle Hypertension, Excitation, and Insomnia, Possibly Related with the Administration of Bupleurum Root Containing Formulations, for 7 Cases of Severe Mental and Physical Disabilities, or Developmental Disorder. Kampo Medicine. https://doi.org/10.3937/kampomed.61.36
170. Hirano, M., Bloch, C. S., & Gould, W. J. (1982). None. Practica Oto-Rhino-Laryngologica. https://doi.org/10.5631/jibirin.75.1395
171. Hirose, S. (2003). The Causes of Underdiagnosing Akathisia. Schizophrenia Bulletin. https://doi.org/10.1093/oxfordjournals.schbul.a007027
172. Hodapp, R. M. (1997). Direct and Indirect Behavioral Effects of Different Genetic Disorders of Mental Retardation. American Journal on Mental Retardation. https://doi.org/10.1352/0895-8017(1997)102<0067:daibeo>2.0.co;2
173. Hoek, H. W., & Harten, P. N. V. (2009). How to Examine a Patient with Movement Disorders?. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70348-7
174. Holden, S. K., & Hall, D. A. (2016). Ataxia. https://doi.org/10.1002/9781118474075.ch8
175. Hong, C. (2013). 분과 심포지움 2. 임상 : 새로운 진단체계 DSM-5; 조현병 스펙트럼 및 기타 정신병적 장애,성격장애. 한국심리학회 연차 학술발표논문집.
176. Hong, C. (2013). 조현병 스펙트럼 및 기타 정신병적 장애, 성격장애. 한국심리학회 학술대회 자료집.
177. Hoon, D. (2012). Traumatic Experiences Disrupt Amygdala – Prefrontal Connectivity. InTech eBooks. https://doi.org/10.5772/48691
178. Howard, A., Robbins-Welty, G. A., Schindler, N., Kincaid, B. M., & Komisar, J. (2024). Misdiagnosis of Primary Eating Disorder in an Individual With Major Depressive Disorder and Comorbid Catatonic Syndrome. Journal of Psychiatric Practice. https://doi.org/10.1097/pra.0000000000000825
179. Hoyt, M. F. (1987). Notes on Psychotherapy with Obsessed Patients. The Psychotherapy Patient. https://doi.org/10.1300/j358v03n02_02
180. Hubble, J., Busenbark, K., Pahwa, R., Lyons, K. E., & Koller, W. C. (1997). Clinical expression of essential tremor: Effects of gender and age. Movement Disorders. https://doi.org/10.1002/mds.870120620
181. Hughes, W. (2012). Hypnotism. The Encyclopedia of the Gothic. https://doi.org/10.1002/9781118398500.wbeotgh010
182. Huprich, S. K. (2010). Schizoid Personality Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0819
183. Iacono, D. (2024). Womb, gravity, and space: shifting towards the cerebellum-basal ganglia paradigm in dystonia. Dystonia. https://doi.org/10.3389/dyst.2024.13871
184. Ilbeigi, M. S., Davidson, M., & Yarmush, J. (1998). An Unexpected Arousal Effect of Etomidate in a Patient on High-dose Steroids . Anesthesiology. https://doi.org/10.1097/00000542-199812000-00045
185. Indriyanti, D., Sutini, T., Hernawaty, T., & Rafiyah, I. (2024). MASALAH RISIKO PERILAKU KEKERASAN PADA PASIEN SKIZOAFEKTIF DI RSJ CISARUA: LAPORAN KASUS. SENTRI Jurnal Riset Ilmiah. https://doi.org/10.55681/sentri.v3i6.2990
186. Ionov, A., & Schröder, S. G. (2024). Rigor mit Hyperthermie. Nervenheilkunde. https://doi.org/10.1055/a-2115-7649
187. Isac, A. Y., Boboc, C., & Lupu, V. (2017). Treatment difficulties in the pathology of the frontal lobe. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.548
188. Jenkinson, P. M., Edelstyn, N. M., Preston, C., & Ellis, S. J. (2014). Anarchic hand with abnormal agency following right inferior parietal lobe damage: a case report. Neurocase. https://doi.org/10.1080/13554794.2014.925936
189. Johnson, P. L., Webber, H. E., Wu, M. S., Lewin, A. B., Murphy, T. K., & Storch, E. A. (2013). When selective audiovisual stimuli become unbearable: a case series on pediatric misophonia. Neuropsychiatry. https://doi.org/10.2217/npy.13.70
190. Jones, R. S. P. (1988). Treating high‐rate stereotyped behaviours in children. Child Care Health and Development. https://doi.org/10.1111/j.1365-2214.1988.tb00573.x
191. Jp, G., & Guinand, N. (2015). [Vestibular function: the 6th sense... ignored].. PubMed.
192. Kalivas, P. W. (2003). Development and Expression of Behavioral Sensitization. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_9
193. Kalivas, P. W., Toda, S., Bowers, M. S., Baker, D. L., & Ghasemzadeh, M. B. (2003). The Temporal Sequence of Changes in Gene Expression by Drugs of Abuse. Humana Press eBooks. https://doi.org/10.1385/1-59259-358-5:03
194. Kanchanatawan, B., & Kasantikul, D. (2007). Antipsychotic-induced tardive movement disorders: a series of twelve cases.. PubMed.
195. Kap, Y. S. (2010). A Primate View on Multiple Sclerosis.
196. Kara, N. (2014). Cognitive Behavioral Therapy of a Generalized Anxiety Disorder Case Comorbid with Health Anxiety. Journal of Cognitive-Behavioral Psychotherapy and Research. https://doi.org/10.5455/jcbpr.158133
197. Karthik, M. S., & Prabhu, N. (2014). Temporomandibular joint dislocation due to atypical antipsychotic-induced acute dystonia: a case report. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125314553970
198. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
199. Kemeny, M. E. (2003). The Psychobiology of Stress. Current Directions in Psychological Science. https://doi.org/10.1111/1467-8721.01246
200. Kenar, S. G., Leba, L. K., Genç, B. O., & Genç, E. (2024). “Tweeting” Seizures in a Patient with Tuberous Sclerosis with Refractory Epilepsy. Neurological Sciences and Neurophysiology. https://doi.org/10.4103/nsn.nsn_97_23
201. Kennedy, J. E., Jaffee, M. S., & Cooper, D. (2013). Posttraumatic Stress Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da08
202. Kenneth, M. H. (2004). Intentional neglect. Frontiers in bioscience. https://doi.org/10.2741/1261
203. Keulen, S., Verhoeven, J., Bastiaanse, R., & Mariën, P. (2014). Foreign accent syndrome: A typological overview. Stem- Spraak- en Taalpathologie.
204. Khaikin, Y., & Mercimek‐Andrews, S. (2016). STXBP1 Encephalopathy with Epilepsy.
205. Khan, A. U. (1974). Mechanism of Psychogenic Asthmatic Attack in Children. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000286689
206. Kim, J.-Y., Kang, N.-I., & Yang, J. (2015). A Case of Clinical Application of Covert Sensitization in a Patient with Kleptomania. Journal of Korean Neuropsychiatric Association. https://doi.org/10.4306/jknpa.2015.54.1.127
207. King, A., Rawitt, R. R., Barboza, K. C., & Hollander, E. (2003). Cognitive and Neuropsychological Assessment of Children with Autism Spectrum Disorders. CRC Press eBooks. https://doi.org/10.3109/9780203911723-9
208. Kinney, M., & Craig, J. (2015). Grand Rounds: An Update on Convulsive Status Epilepticus.. PubMed.
209. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
210. Koshy, R., & Sudha, P. (2011). Nonconvulsive status epilepticus: An unusual cause of postoperative unresponsiveness following general anaesthesia. Indian Journal of Anaesthesia. https://doi.org/10.4103/0019-5049.79901
211. Kraakevik, J., & Schoneburg, B. (2016). Common Types of Tremor. https://doi.org/10.1002/9781118474075.ch3
212. Krantz, D. S., Gabbay, F. H., Hedges, S. M., Klein, J., NEBEL, L. E., Helmers, K. F., Patterson, S., SAMETH, J. L., Gottdiener, J. S., & Rozanski, A. (1991). Behavioral Triggers of Silent and Symptomatic Myocardial Ischemia. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/j.1540-8167.1991.tb01376.x
213. Kreitler, S., & Niv, D. (2001). Pain and alexithymia: The nature of a relation. The Pain Clinic. https://doi.org/10.1163/15685690152385745
214. Kumar, N. (2014). Sevoflurane in child with carpus callosum agenesis syndrome, a series of four cases.
215. Kumar, S., & Browne, M. O. (2003). What are the effects of drug treatments for panic disorder?. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.6.2.34
216. Kurvits, L., Mainka, T., Cavanna, A. E., Kühn, A. A., & Ganos, C. (2021). Aggression Toward Others Misdiagnosed as Primary Tics. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13236
217. Kushner, H. I., & Cortes, D. (2000). Gilles De La Tourette’S Syndrome. https://doi.org/10.1093/oso/9780195133660.003.0033
218. Kushner, H. I., & Cortes, D. (2000). Sydenham’S Chorea. https://doi.org/10.1093/oso/9780195133660.003.0053
219. Langbour, N. (2012). Perturbations des processus d’intégration sensori-motrice dans la crampe de l’écrivain : une étude physiopathologique combinant imagerie par résonance magnétique fonctionnelle et électroencéphalographie-haute résolution.
220. Lansky, M. R. (1989). The Explanation of Impulsive Action. British Journal of Psychotherapy. https://doi.org/10.1111/j.1752-0118.1989.tb01259.x
221. Larun, L., Brurberg, K. G., Odgaard‐Jensen, J., & Price, J. (2016). Exercise therapy for chronic fatigue syndrome. Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd003200.pub5
222. Larun, L., Brurberg, K. G., Odgaard‐Jensen, J., & Price, J. (2016). Exercise therapy for chronic fatigue syndrome. Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd003200.pub6
223. Latt, N., Conigrave, K. M., Saunders, J. B., Marshall, E. J., & Nutt, D. (2009). Chapter 10 Other drugs. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199539338.003.0010
224. Lawrie, S. M. (2010). Schizophrenia, bipolar disorder, obsessive–compulsive disorder, and personality disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260507
225. Lawson, D. M., Davis, D., & Brandon, S. (2013). Treating complex trauma: Critical interventions with adults who experienced ongoing trauma in childhood.. Psychotherapy. https://doi.org/10.1037/a0032677
226. Lawson, W., & Dombroski, B. A. (2017). Problems with Object Permanence: Rethinking Traditional Beliefs Associated with Poor Theory of Mind in Autism. Journal of Intellectual Disability - Diagnosis and Treatment. https://doi.org/10.6000/2292-2598.2017.05.01.1
227. Lebedinskaia, K. S. (1980). [Clinical systematics of retarded mental development].. PubMed.
228. Leddy, J. J., Hinds, A., Sirica, D., & Willer, B. (2016). The Role of Controlled Exercise in Concussion Management. PM&R. https://doi.org/10.1016/j.pmrj.2015.10.017
229. Lee, M. A., McGlinch, E. B., McGlinch, M., & Capacchione, J. F. (2017). Malignant Hyperthermia Susceptibility and Fitness for Duty. Military Medicine. https://doi.org/10.7205/milmed-d-16-00186
230. Leggin, B. G., Shaffer, M. A., Neuman, R. M., Williams, G. R., & Annotti, J. P. I. (2003). Relationship of the Penn Shoulder Score with Measures of Range of Motion and Strength in Patients with Shoulder Disorders: A Preliminary Report.
231. Leiblum, S. R. (2003). Arousal disorders in women: complaints and complexities. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2003.tb05392.x
232. Lenz, G. R., Schoepke, H. G., & Spaulding, T. C. (2000). Anesthetics. Kirk-Othmer Encyclopedia of Chemical Technology. https://doi.org/10.1002/0471238961.0114051912051426.a01
233. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
234. Lheureux, P., & Penaloza, A. (2002). [Ototoxicity-related vertigo].. PubMed.
235. Liang, J., Ewoldt, R. H., Tippett, S. R., & Hsiao‐Wecksler, E. T. (2016). Design and Modeling of a Passive Hydraulic Device for Muscle Spasticity Simulation1. Journal of Medical Devices. https://doi.org/10.1115/1.4033247
236. Lim, E. C., & Seet, R. C. (2007). What is the place for placebo in the management of psychogenic disease?. Journal of the Royal Society of Medicine. https://doi.org/10.1177/014107680710000202
237. Lim, H. J., Kwon, Y. J., Lee, J. E., & Cho, S. (2013). Original article : Reconsideration of Psychasthenia- Two Cases. 동의신경정신과학회지.
238. Lim, H., Kwon, Y.-J., Lee, J.-E., & Cho, S. (2013). Reconsideration of Psychasthenia- Two Cases. Journal of Oriental Neuropsychiatry. https://doi.org/10.7231/jon.2013.24.3.245
239. Lin, Z., & Richard, W. D. (2012). Changes of Sympathovagal Balance Measured by Heart Rate Variability in Gastroparetic Patients Treated with Gastric Electrical Stimulation. InTech eBooks. https://doi.org/10.5772/23052
240. Linssen, M., Delnooz, C. C., & Warrenburg, B. V. D. (2013). Two Task-Specific Dystonias in One Hand. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.149
241. Liptak, G. S. (1998). THE CHILD WHO HAS SEVERE NEUROLOGIC IMPAIRMENT. Pediatric Clinics of North America. https://doi.org/10.1016/s0031-3955(05)70586-1
242. Louis, E. D. (2016). Treatment of Medically Refractory Essential Tremor. New England Journal of Medicine. https://doi.org/10.1056/nejme1606517
243. Loyola, D. P. (2010). Truques sensoriais em diferentes tipos de distonia e no espasmo hemifacial.
244. Lyerly, O. G., & Weinstein, E. A. (1966). Conversion Hysteria Following Brain Injury. Archives of Neurology. https://doi.org/10.1001/archneur.1966.00470170099012
245. Lévy, R. (2021). Apathy. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198841807.003.0009
246. Lütschg, J., Zaugg, C., & Hassink, R. (2012). Neuropédiatrie: Rare mais importante: la dystonie dopa-sensible ou syndrome de Segawa (DYT5). Forum Médical Suisse ‒ Swiss Medical Forum. https://doi.org/10.4414/fms.2012.01378
247. Ma, J., & Junqué, C. (2001). [Criminal behavior after orbitofrontal lesion].. PubMed.
248. MacDonald, D. B. (2002). Safety of Intraoperative Transcranial Electrical Stimulation Motor Evoked Potential Monitoring. Journal of Clinical Neurophysiology. https://doi.org/10.1097/00004691-200210000-00005
249. Mackay, C. E. (2023). Trichotillomania: a perspective synthesised from neuroscience and lived experience. BMJ Mental Health. https://doi.org/10.1136/bmjment-2023-300795
250. Maeda, M., Nagasawa, H., Yorizumi, K., Sayama, S., & Ogino, H. (1991). Compulsive Manipulation of Tools and Its Clinical Symptomatology.. Shitsugoshō kenkyū/Shitsugoshou kenkyuu. https://doi.org/10.2496/apr.11.187
251. Mahmoud, O., Azab, H., Mohammed, Y., & Sayed, T. A. (2022). Early intervention for challenging behaviour in intellectual disability. Sohag Medical Journal. https://doi.org/10.21608/smj.2022.159565.1342
252. Maleki, N., Becerra, L., & Borsook, D. (2012). Migraine: Maladaptive Brain Responses to Stress. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2012.02241.x
253. Mansoori, R. A., Maskari, B. A., & Memari, S. A. (2024). History Taking and Management of a Child Presenting with Enuresis. https://doi.org/10.1007/978-981-99-5530-5_42
254. Marazziti, D. (2003). Autism, Serotonin, and the Cerebellum: A New, Comprehensive Hypothesis. CRC Press eBooks. https://doi.org/10.3109/9780203911723-15
255. Marcel, C., & Tranchant, C. (2012). Prise en charge thérapeutique des mouvements anormaux. Médecine thérapeutique. https://doi.org/10.1684/met.2012.0358
256. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
257. Marshall, J. C., Gurd, J. M., & Fink, G. R. (2002). Catatonia, motor neglect, and hysterical paralysis: Some similarities and differences. Behavioral and Brain Sciences. https://doi.org/10.1017/s0140525x02320107
258. Martens, W. H. J., & Kahn, W. A. (2003). Emotional Capacities and Sensitivity in Psychopaths.
259. Mc, H., Schmer, D., Waingortin, D., Cervone, N., & Ma, F. (1976). [Study and treatment of the drug addict and his family].. PubMed.
260. McFayden, T. C., Kennison, S. M., & Bowers, J. M. (2022). Echolalia from a transdiagnostic perspective. Autism & Developmental Language Impairments. https://doi.org/10.1177/23969415221140464
261. McSweeney, F. K., & Swindell, S. (2002). Common Processes May Contribute to Extinction and Habituation. The Journal of General Psychology. https://doi.org/10.1080/00221300209602103
262. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
263. Meehl, P. E. (1989). Schizotaxia Revisited. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1989.01810100077015
264. Menezes, M. C. D. C., Gonçalves, L. G. V., Chaves, S. C. D. S., Jaime, T. F. M., Oliveira, I. C. Z., Sobrinho, K. D. L., Oliveira, L. L. D., Araújo, J. V. L. D., Gurian, F. G., Soares, I. L. T., Nero, L. D., Pereira, P. H. D. O., Moraes, F. D. C., & Teixeira, G. P. (2023). MAIN CAUSES OF INTENTIONAL ACCIDENTS IN PEDIATRICS AND CLINICAL MANIFESTATIONS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593712308095
265. Mercolini, F., Scarabel, F., Leo, V. D., Nosadini, M., Toldo, I., & Sartori, S. (2015). Baby Jerking: A Teaching Video‐Recorded Case of Febrile Myoclonus. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12203
266. Merino, C. F., & Pichel, A. R. (2023). Temblor y principales entidades a las que se asocia. Actualización en Medicina de Familia. https://doi.org/10.55783/amf.190202
267. Mervis, C. Β., Morris, C. A., Klein-Tasman, B., Velleman, S. L., & Osborne, L. R. (2015). 7q11.23 Duplication Syndrome.
268. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
269. Michelson, D., Gold, P. W., & Sternberg, E. M. (1994). The stress response in critical illness.. PubMed.
270. Michie, S. (2002). CAUSES AND MANAGEMENT OF STRESS AT WORK. Occupational and Environmental Medicine. https://doi.org/10.1136/oem.59.1.67
271. Miettinen, O. S., & Flegel, K. M. (2003). Elementary concepts of medicine: VII. Course of illness: manifestations, complications, outcome. Journal of Evaluation in Clinical Practice. https://doi.org/10.1046/j.1365-2753.2003.00420.x
272. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
273. Mink, J. W., & Zinner, S. H. (2010). Movement Disorders II: Chorea, Dystonia, Myoclonus, and Tremor. Pediatrics in Review. https://doi.org/10.1542/pir.31.7.287
274. Mir, J. A., Mushtaq, B., & Mushtaq, O. A. (2022). Clinical case report on bipolar affective disorder, mania. IP Journal of Paediatrics and Nursing Science. https://doi.org/10.18231/j.ijpns.2022.007
275. MM, B. (2016). Deformities of Cerebral Palsy Treated By Ilizarov Technique. MOJ Orthopedics & Rheumatology. https://doi.org/10.15406/mojor.2016.04.00121
276. MM, B., Islam, S., Nh, S., Rahman, M., & Bari, M. (2016). None. MOJ Orthopedics & Rheumatology. https://doi.org/10.15406/mojor.4.1
277. Modoni, S., Urbano, N., Trivisano, M., Pascarella, M. G., D’Orsi, G., Claudio, T. D., & Specchio, L. M. (2013). Brain SPECT Imaging of Ictal Smile Seizure. Clinical Nuclear Medicine. https://doi.org/10.1097/rlu.0b013e3182387477
278. Mohite, S., Osman, O. T., Shahani, L., & Teixeira, A. L. (2022). Akathisia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574317.003.0004
279. Mohr, P. (2022). Treating Catatonia: a Blind Spot of Psychiatry?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.143
280. Molla, L., Preza, K., & Simaku, A. (2021). Low Back Pain Diagnostic Approach. Medicus. https://doi.org/10.58944/bcsf1353
281. Morra, M. (2002). Some considerations about personality structure in child psychosis. Journal of Child Psychotherapy. https://doi.org/10.1080/0075417021000022621
282. Moscovich, M., Estupinan, D., Qureshi, M. Y., & Okun, M. S. (2013). Shell shock: Psychogenic gait and other movement disorders-A film review.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.7916/d89023hj
283. Moscovich, M., Estupinan, D., Qureshi, M. Y., & Okun, M. S. (2013). Shell shock: Psychogenic gait and other movement disorders—A film review. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.132
284. Motevalli, H., Hosseinzadeh, R., Barary, M., Sio, T. T., & Manouchehri, A. (2022). Acute poisoning due to massive leaking of methamphetamine in a methamphetamine body packer: A case report. Authorea (Authorea). https://doi.org/10.22541/au.164761079.96603410/v1
285. Muniz, J., Walia, G. S., Agarwal, P., Salehi, M., & Grados, M. A. (2024). P430: Genetically-determined variants lead to neuronal hyperexcitability and clinical psychosis/catatonia: Case series. Genetics in Medicine Open. https://doi.org/10.1016/j.gimo.2024.101324
286. Murayama, K., Greenwood, R., Rao, K. W., & Aylsworth, A. S. (1991). Neurological aspects of del(1q) syndrome. American Journal of Medical Genetics. https://doi.org/10.1002/ajmg.1320400424
287. Murray, K. F., & Christie, D. L. (1998). Vomiting. Pediatrics in Review. https://doi.org/10.1542/pir.19-10-337
288. Murray, K. F., & Christie, D. L. (1998). Vomiting. Pediatrics in Review. https://doi.org/10.1542/pir.19.10.337
289. Méndez, A. V., Silva, P. L. N. D., Gonçalves, L. G. V., Chaves, S. C. D. S., Veiga, R. M., Mendez, A. E. R., Camilo, M. V. L., Mattos, L. C. D. A. N., Filho, M. R. S., Silva, R. D. G. D., Lima, G. F., Ferreira, C. S., & Santos, L. G. D. S. (2023). NEURONAL DAMAGE IN STATE EPILEPTICUS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593752318094
290. Naguy, A. (2015). Acamprosate Complements Ill-Sustained Response of ECT in Catatonic Frontotemporal Dementia. Journal of Psychiatry. https://doi.org/10.4172/2378-5756.1000292
291. Nambu, A. (2012). Pathophysiology of movement disorders. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.52.1198
292. Nambu, A., Tachibana, Y., & Chiken, S. (2014). Cause of parkinsonian symptoms: Firing rate, firing pattern or dynamic activity changes?. Basal Ganglia. https://doi.org/10.1016/j.baga.2014.11.001
293. ndez, J. M. P.-Á., Iniesta-López, I., & López-Agreda, J. M. (2002). Asociación entre encefalopatía postanóxica y epilepsia del sobresalto. Revista de Neurología. https://doi.org/10.33588/rn.3407.2001362
294. Neto, B. P. F. (2009). Catatonia with Left Temporal Lesion on MRI: Crossing Borders. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70960-5
295. Newkirk, B., Jimenez, A. A., & Fink, J. L. (2024). B - 11 Alien Limb and Corticobasal Degeneration: a Neuropsychological Case Study. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acae067.172
296. Nogueira, J. M., Ramos, C. P., Baptista, C., Mendes, S., & Gamito, A. (2024). The Impulsivity-Compulsivity Spectrum: Understanding Brain Mechanisms and Clinical Implications. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1303
297. Nomura, S., Yamaoka, K., & Naitoh, H. (1989). [Studies on animal model of depression: review and perspective].. PubMed.
298. Noy, S. (2001). Gradations of stress as determinants of the clinical picture immediately after traumatic events.. Traumatology An International Journal. https://doi.org/10.1177/153476560100700301
299. Ogunlela, A., & Raai, H. (2022). Catatonia; A Case Study and Literature Review. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1988
300. Orlando, F. A., Malaty, J., Williams, M., & Tudeen, M. (2024). Otology: Vertigo.. PubMed.
301. Ortiz, S. R., Carrillo-Albornoz, E. J. O., & Coque, J. A. R. (2016). La intervención policial con sujetos confuso-agitados: El denominado “delirio agitado”. Cuadernos de la Guardia Civil: Revista de seguridad pública.
302. Osama, M., Bonnechère, B., & Afridi, S. (2024). Unsupervised mobility and motion assessment in neuromuscular and musculoskeletal disorders using mobile health technology. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.10657
303. Osiurak, F., & Gall, D. L. (2012). Apraxia: Clinical Types, Theoretical Models, and Evaluation. https://doi.org/10.5772/47986
304. Osterman, J. E., Erdos, B. Z., Oldham, M., & Ivkovic, A. (2010). Antidepressant Treatments in PTSD. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-435-7_7
305. Pannill, F. C. (1987). Urinary Incontinence1. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1987.tb02342.x
306. Panyakaew, P., Phuenpathom, W., Bhidayasiri, R., & Hallett, M. (2024). Bedside clinical assessment of patients with common upper limb tremor and algorithmic approach. Asian Biomedicine. https://doi.org/10.2478/abm-2024-0008
307. Park, J. S., Belfort, M. A., & Norwitz, E. R. (2001). Pathogenesis and treatment of eclampsia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545634.030
308. Pasquier, F., & Petit, H. (1997). Frontotemporal Dementia: Its Rediscovery. European Neurology. https://doi.org/10.1159/000112894
309. Pe, M., Scaff, M., Cossermelli, W., Aj, B.-F., Jl, D. A., Pereira, R. M. R., & Rm, D. O. (1989). Nervous system involvement in systemic lupus erythematosus: report of three cases.. PubMed.
310. Pelliccia, V., Avanzini, P., Rizzi, M., Caruana, F., Tassi, L., Francione, S., Gozzo, F., Mariani, V., d’Orio, P., Castana, L., Mai, R., Terzaghi, M., Nobili, L., & Sartori, I. (2022). Association Between Semiology and Anatomo-functional Localization in Patients With Cingulate Epilepsy. Neurology. https://doi.org/10.1212/wnl.0000000000200145
311. Persinger, M. A. (1989). Geophysical Variables and Behavior: LV. Predicting the Details of Visitor Experiences and the Personality of Experients: The Temporal Lobe Factor. Perceptual and Motor Skills. https://doi.org/10.2466/pms.1989.68.1.55
312. Perugi, G. (2010). Cyclothymic temperament and/or borderline personality disorder. Annals of General Psychiatry. https://doi.org/10.1186/1744-859x-9-s1-s77
313. Piacentini, J., & Bennett, S. M. (2010). Tourette's Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1001
314. Pich, E. M., Heidbreder, C., Mugnaini, M., & Teneggi, V. (2003). Molecular and Behavioral Aspects of Nicotine Dependence and Reward. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_16
315. Pimiento, A. P., Parra, B. F., Montoya, M. S., Arranz, S., & Domínguez, A. R. (2001). Síndrome de anafilaxia inducida por ejercicio. Anales de Medicina Interna. https://doi.org/10.4321/s0212-71992001000500010
316. Pirke, K., Fichter, M., Schweiger, U., Krieg, C., Ploog, D., & Remschmidt, H. (2000). Langversion der Behandlungsleitlinie Eßstörungen. Steinkopff eBooks. https://doi.org/10.1007/978-3-642-57730-7_1
317. Pl, G. (1977). Alienation: character neuroses and narcissistic disorders.. PubMed.
318. Plummer, P., Morris, M. E., & Dunai, J. (2003). Assessment of Unilateral Neglect. Physical Therapy. https://doi.org/10.1093/ptj/83.8.732
319. Pohjolainen, T., Leinonen, V., Frantén, J., Haanpää, M., Jousimaa, J., Karppinen, J., Kuukkanen, T., Luoma, K., Salmenkivi, J., Österman, H., Malmivaara, A., & Päivitystiivistelmä (2015). [Update on Current Care Guideline: Low back pain].. PubMed.
320. Poncet, M., & Ceccaldi, M. (1991). [The frontiers of aphasia].. PubMed.
321. Poncet, M., & Ceccaldi, M. (1991). The frontiers of aphasia.
322. Pontius, A. A. (1984). Specific Stimulus-Evoked Violent Action in Psychotic Trigger Reaction: A Seizure-like Imbalance between Frontal Lobe and Limbic Systems?. Perceptual and Motor Skills. https://doi.org/10.2466/pms.1984.59.1.299
323. Pontius, A. A. (1988). Limbic System-Frontal Lobes' Role in Subtypes of “Atypical Rape”. Psychological Reports. https://doi.org/10.2466/pr0.1988.63.3.879
324. Poyato, F. X. B., & García, A. A. (2016). Sensibilización de la respuesta emocional y neuroendocrina al estrés.
325. Pratibha, S. (2010). Etiology of Late Onset Seizures.
326. Prato, C. D., Bastin, M.-H., & Preiser, J. (2009). Sarcopénie en réanimation. Réanimation. https://doi.org/10.1016/j.reaurg.2009.06.017
327. Priya, S., & Nambi, S. (2013). Dissociative identity disorder: An uncommon psychiatric disorder reported. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.120565
328. Pujol, R., & Puel, J. (1999). Excitotoxicity, Synaptic Repair, and Functional Recovery in the Mammalian Cochlea: A Review of Recent Findings. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1999.tb08646.x
329. Pursnani, S., Sobhani, A., Chandi, A. K., Bhardwaj, A., & Kumar, N. (2024). A Rare Case of rTMS Induced Schizophrenia Symptom Switch. BJPsych Open. https://doi.org/10.1192/bjo.2024.690
330. Putilina, M. V. (2024). Asthenic disorders: contradictions and paradigms. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/ms2024-122
331. Pérez, Y. M. M., Ortega, D. L. G., & Torres, S. V. L. (2022). AGITACIÓN PSICOMOTRIZ. PUERTO MADERO EDITORIAL eBooks. https://doi.org/10.55204/pmea.3.c10
332. Ramcharan, K., Hosein, N., Teelucksingh, J. D., Rampersad, F., & Teelucksingh, S. (2016). Prominent Bilateral Hand Tremor in Hashimoto’s Encephalopathy: A Video Demonstration. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.305
333. Ramig, L. O., & Verdolini, K. (1998). Treatment Efficacy. Journal of Speech Language and Hearing Research. https://doi.org/10.1044/jslhr.4101.s101
334. Rani, M. K. S., Fathima, S. T., Gayathri, S. L., Pavani, M., & Swathi, Y. (2022). Detection of Autism Spectrum Disorder using Machine Learning. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-7600
335. Rastogi, R., Swarm, R. A., Patel, T., & Riou, B. (2011). Case Scenario: Opioid Association with Serotonin Syndrome. Anesthesiology. https://doi.org/10.1097/aln.0b013e31823940c0
336. Račkauskaitė, J., Danilevičiūtė, V., & Navickas, A. (2014). Haliucinacijų etiologijos aspektai. Sveikatos mokslai. https://doi.org/10.5200/sm-hs.2014.013
337. Reese, R., & Volkmann, J. (2014). Deep brain stimulation for dystonia. https://doi.org/10.2217/ebo.13.97
338. Renzullo, A. M., Benvenuto, S., Nait, G., & Pennesi, M. (2024). L'enuresi notturna: in quadramento e gestione. Medico e Bambino. https://doi.org/10.53126/meb43499
339. Richardson, M. (2003). Anxiety in childhood. https://doi.org/10.4225/50/5552e75abb9b8
340. Richter, W., & Otto, C. (1997). [Hypoglycemia. Symptoms, differential diagnosis, therapy].. PubMed.
341. Robertson, M. M. (2003). Heterogeneous Psychopathology of Tourette Syndrome. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-326-2_33
342. Rodrigo, M. L., Monge, M. P., Fominaya, M. P., Oliver, A. O., Guerra, M. T., Montero, C. G., & Font, V. R. (2022). Two of us live in this body. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.2256
343. Rodríguez, E. O., Esquivel, P. S., & Triana, I. M. (2024). Un panorama actualizado de la dispepsia. Revista médica de Panamá. https://doi.org/10.37980/im.journal.rmdp.20242296
344. Rogers, J., Shorvon, S., & Luccarelli, J. (2024). Catatonia and epilepsy: An underappreciated relationship. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109983
345. Rojas-Estapé, M., Berenger-Elias, N., & Iglesias-Rodriguez, C. (2012). P-165 - A case of hydrocephalus occlusus presenting as a manic episode. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)74332-8
346. Rosebush, P. I., & Mazurek, M. F. (2007). Catatonia. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-960-8_8
347. Rousseau, P. (1988). Impotence in elderly men. Postgraduate Medicine. https://doi.org/10.1080/00325481.1988.11700270
348. Roze, E., Silveira‐Moriyama, L., Leu‐Semenescu, S., Villeneuve, N., Lecardonnel, B., François‐Heude, M., Meyer, P., Gusmão, C. M. D., & Roubertie, A. (2024). <scp><i>KCNMA1‐Related</i></scp> Episodes of Behavioral Arrest and Loss of Postural Reflexes: A Critical Reappraisal. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14289
349. Ruggieri, V., & Arberas, C. (2013). [Non-epileptic motor paroxysmal phenomena in wakefulness in childhood].. PubMed.
350. Ruggieri, V., & Arberas, C. (2013). Fenómenos paroxísticos no epilépticos motores en vigilia en la infancia. Revista de Neurología. https://doi.org/10.33588/rn.57s01.2013206
351. Sakti, N. M. W. K. (2016). PENANGANAN VERTIGO MENGGUNAKAN AKUPUNKTUR TITIK FENGCHI (GB 20), ZUSANLI (ST 36), SANYINJIAO (SP 6), SHEN MEN (HT 7) DAN HERBAL DAUN SEREH (CYMBOPOGON CITRATUS), KAYU MANIS (CINNAMOMUM BURMANII).
352. Salama, A. Z., Dabash, M. R., Elayan, A., Saadeh, S., & Ikhmayyes, I. (2024). Dissociative Trance Led to a Catastrophe: A Case Report. Cureus. https://doi.org/10.7759/cureus.76458
353. Salim, M. S., & Anjum, Q. (2003). Role of nerve blocks in chronic pain managementi. Rawal Medical Journal.
354. Sandi, C. (2013). Stress and cognition. Wiley Interdisciplinary Reviews Cognitive Science. https://doi.org/10.1002/wcs.1222
355. Sanger, T. D., Chen, D., Fehlings, D., Hallett, M., Lang, A. E., Mink, J. W., Singer, H. S., Alter, K. E., Ben‐Pazi, H., Butler, E. E., Chen, R., Collins, A., Dayanidhi, S., Forssberg, H., Fowler, E., Gilbert, D. L., Gorman, S. L., Gormley, M., Jinnah, H. A., ... Valero‐Cuevas, F. J. (2010). Definition and classification of hyperkinetic movements in childhood. Movement Disorders. https://doi.org/10.1002/mds.23088
356. Sanxhaku, D., Kodra, V., Alikaj, V., Allkoja, B., & Zenelaj, B. (2017). Child obsessive-compulsive disorder presenting with catatonic-like features: Case presentation. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.461
357. Schildkrout, B. (2011). Characteristics That Make Somatic Diseases Difficult to Detect. https://doi.org/10.1002/9781118083598.ch3
358. Schildkrout, B. (2011). Specific Mental Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch9
359. Schoene, D., & Sturnieks, D. L. (2021). Cognitive-Motor Interventions and Their Effects on Fall Risk in Older People. Cambridge University Press eBooks. https://doi.org/10.1017/9781108594455.019
360. Scholly, J., Valenti, M., Staack, A. M., Strobl, K., Bast, T., Kehrli, P., Steinhoff, B. J., & Hirsch, É. (2013). Hypothalamic hamartoma: Is the epileptogenic zone always hypothalamic? Arguments for independent (third stage) secondary epileptogenesis. Epilepsia. https://doi.org/10.1111/epi.12456
361. Schrock, L. E., Xie, T., & Barton, B. (2016). None. https://doi.org/10.1002/9781118474075.ch7
362. Schweitzer, J. B. (2010). Attention‐Deficit/Hyperactivity Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0096
363. Schäfer, I., Kurth, R., & Gerhardt, H. (2011). Posttraumatische und psychotische Symptome bei schwer traumatisierten Patienten. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0031-1281801
364. Scott, S., & Stone, J. (2014). iPhone-responsive functional gait disorder: Table 1. Practical Neurology. https://doi.org/10.1136/practneurol-2014-000873
365. Sexmero, M. M., Carrasco, I. S., Cerejeira, J. G., Lozano, M. F., Ramírez, A. G., Viuda, M. Q. D. L. D. L., Valera, G. G., Adame, C. V., Lobo, C. D. A., Aparicio, T. J., Rodríguez, B. R., Barriga, N. N., Pérez, E. R., & Borge, L. G. (2022). Mutism. What to expect?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1507
366. Shah, S. K. (2010). DEFICITS AFFECTING THE FUNCTION OF THE PARALYSED ARM FOLLOWING HEMIPLEGIA*. Australian Occupational Therapy Journal. https://doi.org/10.1111/j.1440-1630.1978.tb00656.x
367. Shams, J., Rahmani, B., Asefi, F., & Daneshfar, S. (2010). CATATONIA DEVELOPMENT IN A SCHIZOAFFECTIVE PATIENT FOLLOWING ELECTROCONVULSIVE THERAPY: CASE REPORT.
368. Sheikh, S. H., Raibaut, P., Hubeaux, K., Lebreton, F., Verolet, D., & Amarenco, G. (2009). Les explorations non invasives du système nerveux autonome Non-invasive exploration of the autonomic system.
369. SheikhBahaei, S., Farhan, M., & Maguire, G. A. (2022). Improvement of stuttering after administration of methylphenidate - a case report. Personalized Medicine in Psychiatry. https://doi.org/10.1016/j.pmip.2022.100092
370. Shibasaki, H., & Hallett, M. (2022). Involuntary movements. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197556306.003.0019
371. Shkembi, A., Skenderi, E., Imeraj, F., Kuneshka, N., Xhelili, G., & Durma, A. (2023). A case of sexual abuse and art therapy. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2023.18.1.0566
372. Shukla, R., Ahsan, M. N., Pal, A., & Shaan, F. (2024). Unraveling the enigma of ‘Psychological Pillow’: A unique catatonic phenomenon. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_319_23
373. Silverman, M. N., & Deuster, P. A. (2014). Biological mechanisms underlying the role of physical fitness in health and resilience. Interface Focus. https://doi.org/10.1098/rsfs.2014.0040
374. Silverstein, S. M. (2013). Schizophrenia-related phenomena that challenge prediction error as the basis of cognitive functioning. Behavioral and Brain Sciences. https://doi.org/10.1017/s0140525x12002221
375. Singh, J., & Hill, C. M. (2014). G337(P) Rhythmic Movement Disorders of Sleep: Single centre experience of treatment modalities. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2014-306237.320
376. Snowden, J. S., Craufurd, D., Griffiths, H. L., & Neary, D. (1998). Awareness of Involuntary Movements in Huntington Disease. Archives of Neurology. https://doi.org/10.1001/archneur.55.6.801
377. Sobrinho, L. G. (1998). Emotional Aspects of Hyperprolactinemia. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000012273
378. Sokolowski, K., Liu, J., Delatte, M. S., Authier, S., McMaster, O., & Bolon, B. (2024). The Role of Neuropathology Evaluation in the Nonclinical Assessment of Seizure Liability. Toxicologic Pathology. https://doi.org/10.1177/01926233241300065
379. Souza, T. D. N., Sonegheti, J. V., Andrade, L. H. R. D., & Tannure, P. N. (2017). Atendimento odontológico em uma criança com transtorno do espectro autista: relato de caso. Revista de Odontologia da Universidade Cidade de São Paulo. https://doi.org/10.26843/ro_unicid.v29i2.278
380. Spence, S. A. (2001). Alien Control: From Phenomenology to Cognitive Neurobiology. Philosophy, psychiatry & psychology. https://doi.org/10.1353/ppp.2001.0017
381. Spence, S. A. (2002). Alien motor phenomena: A window on to agency. Cognitive Neuropsychiatry. https://doi.org/10.1080/13546800244000094
382. Spiegel, D., Chatterjee, A., Mccroskey, A. L., Ahmadi, T., Simmelink, D., Oldfield, E. C., Pryor, C. R., Faschan, M., & Raulli, O. (2015). A Review of Select Centralized Pain Syndromes. Health Services Research and Managerial Epidemiology. https://doi.org/10.1177/2333392814567920
383. Spinella, M. (2004). Clinical Case Report: HYPERSEXUALITY AND DYSEXECUTIVE SYNDROME AFTER A THALAMIC INFARCT. International Journal of Neuroscience. https://doi.org/10.1080/00207450490509339
384. Statler, K. D., Jenkins, L. W., Dixon, C. E., Clark, R. S. B., Marion, D. W., & Kochanek, P. M. (2001). The Simple Model Versus the Super Model: Translating Experimental Traumatic Brain Injury Research to the Bedside. Journal of Neurotrauma. https://doi.org/10.1089/089771501317095232
385. Stearns, M., McCrae, C. S., Curtis, A., Nair, N., Hayse, B., Nadorff, D., & Wilkerson, A. K. (2024). Adolescent sleep mediates maternal depressive problems and parenting behaviors: daughter and son differences in a majority Black and Hispanic sample. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.10996
386. Steichen, R., & Rucquoy, G. (1977). [Couple heterosexual dysfunction in relation to homosexual latency (author's transl)].. PubMed.
387. Stephen, C. D., Dy-Hollins, M., Gusmão, C. M. D., Qahtani, X. A., & Sharma, N. (2023). Dystonias: Clinical Recognition and the Role of Additional Diagnostic Testing. Seminars in Neurology. https://doi.org/10.1055/s-0043-1764292
388. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
389. Swain, S. K., & Dubey, D. (2024). Surgical Treatment of Tinnitus. Matrix Science Medica. https://doi.org/10.4103/mtsm.mtsm_5_23
390. Swartz, C. M., Acosta, D., & Bashir, A. (2003). Diminished ECT Response in Catatonia Due to Chronic Neurologic Condition. Journal of Ect. https://doi.org/10.1097/00124509-200306000-00010
391. Szriber, S. J., Calvo, D., Gouveia, D., & Ponce, F. L. (2013). Disfunção cognitiva canina mimetizando neoplasia cerebral: relato de caso. Revista de Educação Continuada em Medicina Veterinária e Zootecnia do CRMV-SP.
392. Söderpalm, B. (2002). Anticonvulsants: aspects of their mechanisms of action. European Journal of Pain. https://doi.org/10.1053/eujp.2001.0315
393. Takács, R., & Rihmer, Z. (2013). Catatonia in Affective Disorders. Current Psychiatry Reviews. https://doi.org/10.2174/1573400511309020003
394. Tempereau, C. E., Grossman, A., & Brones, M. F. (1987). Psychological Regression and Marital Status: Determinants in Psychiatric Management of Burn Victims. Journal of Burn Care & Rehabilitation. https://doi.org/10.1097/00004630-198707000-00009
395. Thomas, N., & Pantelis, C. (2015). Psychotic Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp535
396. Thukamoto, N. (2009). A case of severe aphasia with movement release phenomenon: stage of guiding gesture that appeared in response. Higher Brain Function Research. https://doi.org/10.2496/hbfr.29.408
397. Tickner, N., Apps, J., Keady, S., & Sutcliffe, A. (2012). An overview of drug therapies used in the treatment of dystonia and spasticity in children. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/archdischild-2011-301170
398. Timperley, J., Leeson, P., Mitchell, A. R., & Betts, T. (2007). Chapter 6 Troubleshooting pacemakers. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198571322.003.0006
399. Tintner, R., & Jankovic, J. (2007). Botulinum toxin. CRC Press eBooks. https://doi.org/10.3109/9780203640487-21
400. Todd, O., & Teale, E. (2016). Delirium: a guide for the general physician. Clinical Medicine. https://doi.org/10.7861/clinmedicine.16-6-s98
401. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
402. Torii, H. (1993). [Motor neglect].. PubMed.
403. Touzin, M. (2002). [Academic difficulties in hyperactive children].. PubMed.
404. Tp, P., & Ms, D. (1987). [The current understanding of so-called exceptional states in the forensic psychiatry clinic].. PubMed.
405. Treiman, D. M. (1991). Psychobiology of ictal aggression.. PubMed.
406. Treisman, G. J., & Clark, M. R. (2011). A Behaviorist Perspective. Advances in psychosomatic medicine. https://doi.org/10.1159/000324063
407. Trill, M. D. (2012). Psychological aspects of depression in cancer patients: an update. Annals of Oncology. https://doi.org/10.1093/annonc/mds350
408. Trosch, R., Comella, C. L., Caroff, S. N., Ondo, W. G., Shillington, A. C., LaChappelle, B., Hauser, R. A., Correll, C. U., & Friedman, J. H. (2023). Reliability of the Clinician’s Tardive Inventory (CTI). CNS Spectrums. https://doi.org/10.1017/s1092852923001347
409. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
410. Uhde, T. W., & Roy-Byrne, P. P. (1988). Exogenous factors in panic disorder: clinical and research implications.. PubMed.
411. Umfrid, C., & Dickerman, A. L. (2023). Somatic Symptom Disorder. https://doi.org/10.1007/978-3-031-26837-3_8
412. Valls, J. M. G., Balsalobre, N. R., Perez, A., Limones, P. C., Quintana, Y. S., & Sanchis, N. S. (2007). Respuesta a la TEC en un caso de trastorno explosivo intermitente refractario.. Anales de psiquiatria.
413. Vennesland, N. (2012). Patofysiologien bak de ikke-rytmiske ufrivillige bevegelsesforstyrrelsene.
414. Vicente, M. O., Gutiérrez, L. E. J. F., & Oves, M. I. R. (2011). ALCOHOLISMO CONSECUTIVO AL TRASTORNO DE PÁNICO. DOAJ (DOAJ: Directory of Open Access Journals).
415. Vicente, S. B., Tavares, M. B., & Siqueira, E. C. D. (2023). Síndrome de Tourette. Revista Eletrônica Acervo Médico. https://doi.org/10.25248/reamed.e12923.2023
416. Villani, C., Sapio, M., Giorgi, V., & Sarzi‐Puttini, P. (2023). POS1338 PHARMAKON OR THE ART THAT HEALS: TRANS-DISCIPLINARY ARTISTIC-TRANSFORMATIVE WORKSHOPS FOR FIBROMYALGIA SYNDROME. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2023-eular.5984
417. Vlčková, A., Strejc, P., Sachl, J., Dreßler, J., & Vajtr, D. (2010). [Another mechanism of décollement].. PubMed.
418. Vn, M. (1989). [Clinical aspects of paroxysmal states in children with depression].. PubMed.
419. Volicer, L. (2017). Importance of Context in Management of Behavioral Symptoms of Dementia. MOJ Gerontology & Geriatrics. https://doi.org/10.15406/mojgg.2017.01.00017
420. Vægter, H. B. (2017). Exercising non-painful muscles can induce hypoalgesia in individuals with chronic pain. Scandinavian Journal of Pain. https://doi.org/10.1016/j.sjpain.2016.12.005
421. Walters, A. S., & Zee, P. C. (2023). Why the worsening at rest and worsening at night criteria for Restless Legs Syndrome are listed separately: review of the circadian literature on RLS and suggestions for future directions. Frontiers in Neurology. https://doi.org/10.3389/fneur.2023.1153273
422. Wang, D., Boo, Y. Y. A., Goh, K. C., & Goveas, R. (2022). Psychiatric causes of behavioural change in adults less than 65 years old. Singapore Medical Journal. https://doi.org/10.4103/singaporemedj.smj-2021-305
423. Wang, S. (2013). Research development of posttraumatic growth and metal health. Chinese Journal of Injury Repair and Wound Healing.
424. Wang, T. V., & Song, P. C. (2022). Neurological Voice Disorders: A Review. International Journal of Head and Neck Surgery. https://doi.org/10.5005/jp-journals-10001-1521
425. Wang, Y., & Zhong, N. (2012). Clinical and Genetic Heterogeneity of Autism. InTech eBooks. https://doi.org/10.5772/48700
426. Warltier, D. C., Šprung, J., Bourke, D. L., Contreras, M. G., Warner, M. E., & Findlay, J. Y. (2003). Perioperative Hearing Impairment. Anesthesiology. https://doi.org/10.1097/00000542-200301000-00036
427. Wichaidit, B. T., Rask, C. U., & Østergaard, J. R. (2014). [Diagnosing functional seizures in children and adolescents].. Research Portal Denmark.
428. Wiebe, D. J., Comstock, R. D., & Nance, M. L. (2011). Concussion research: a public health priority. Injury Prevention. https://doi.org/10.1136/ip.2010.031211
429. Wiegant, V. M. (1991). [Stress].. PubMed.
430. Williams, R. H., Erickson, T. B., & Broussard, L. A. (2000). Evaluating Sympathomimetic Intoxication in an Emergency Setting. Laboratory Medicine. https://doi.org/10.1309/wvx1-6fpv-e2lc-b6yg
431. Willner, P., Bergman, J., & Sanger, D. J. (2009). Behavioural pharmacology of impulse control. Behavioural Pharmacology. https://doi.org/10.1097/01.fbp.0000359407.60839.2d
432. Wilson, W., & Nashold, B. S. (1968). Epileptic Discharges occurring in the Mesencephalon and Thalamus. Epilepsia. https://doi.org/10.1111/j.1528-1157.1968.tb04960.x
433. Wise, R. A. (1982). Neuroleptics and operant behavior: The anhedonia hypothesis. Behavioral and Brain Sciences. https://doi.org/10.1017/s0140525x00010372
434. Wolf, J. M., & Paterson, S. (2010). Lifespan aspects of PDD/autism spectrum disorders (ASD). Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511674815.019
435. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
436. Yang, H., Huang, D.-Q., & Zhu, Y.-B. (2012). [Carbamazepine caused severe drug eruption in treatment of tinnitus].. PubMed.
437. Yang, S. S., Seet, R. C., & Lim, E. C. (2010). Chewing-induced Facial Dystonia. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.v39n9p740
438. Yarrow, K., Johnson, H., Haggard, P., & Rothwell, J. C. (2004). Consistent Chronostasis Effects across Saccade Categories Imply a Subcortical Efferent Trigger. Journal of Cognitive Neuroscience. https://doi.org/10.1162/089892904970780
439. Zawilski, Z. M. (2022). Somatisation as a manifestation of emotional disturbance in children. Pediatria i Medycyna Rodzinna. https://doi.org/10.15557/pimr.2022.0006
440. Zempel, J., & Mano, T. (2014). Myoclonic atonic epilepsy. Neurology. https://doi.org/10.1212/wnl.0000000000000368
441. Zeng, X., Li, P., Kong, Q., Lin, Y., & Wu, Z. (2010). [Vertigo due to neurovascular cross-compression: diagnosis and treatment].. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.
442. Zhang, J., & Zhou, X.-Z. (2014). Recent advance in nonconvulsive status epilepticus. Chinese Journal of Neuromedicine. https://doi.org/10.3760/cma.j.issn.1671-8925.2014.04.026
443. Zinner, S. H., & Mink, J. W. (2010). Movement Disorders I: Tics and Stereotypies. Pediatrics in Review. https://doi.org/10.1542/pir.31-6-223
444. Échenne, B. (2011). Dyskinésies paroxystiques kinésigéniques, non kinésigéniques, induites par l’exercice. Formes primitives et secondaires. Médecine thérapeutique / Pédiatrie. https://doi.org/10.1684/mtp.2011.0371
445. Świerkosz, A., Frankowska, A., Turek, A., Siwek, M., Balachowska, D., & Dudek, D. (2015). Zaburzenia dysocjacyjne czy psychotyczne? Stupor u 23-letniej pacjentki. Psychiatria.
446. Şahin, Ş., Ünsal, M. A., Çınar, N., & Karşıdağ, S. (2015). Olgular Temelinde Artmış İrkilme Yanıtının Gözden Geçirilmesi. Journal of Contemporary Medicine. https://doi.org/10.16899/ctd.75571
447. ́Amato, R. J. D. G. D., Solano, D. B. S., Montaño, J., & Leguizamo, R. L. (2014). Déficit de atención con y sin hiperactividad y su relación con lesiones traumatológicas en niños entre 6 y 12 años en la clínica El Prado de la ciudad de Santa Marta. DOAJ (DOAJ: Directory of Open Access Journals).